Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
>>> Else Nutrition Signs Distribution Agreement with Walmart.com
Else Nutrition Holdings Inc.
August 12, 2021
https://finance.yahoo.com/news/else-nutrition-signs-distribution-agreement-110000268.html
Else Toddler Nutrition to be available at Nation’s Largest Grocery Retailer’s online store by Q4 2021
VANCOUVER, British Columbia, Aug. 12, 2021 (GLOBE NEWSWIRE) -- ELSE NUTRITION HOLDINGS INC. (BABY.V) (BABYF) (0YL.F) ("Else" or the "Company") the plant-based baby, toddler and children nutrition company, announces that it has signed an online distribution agreement with Walmart.com and will be expanding into Walmart’s E-commerce (Walmart.com) marketplace by Q4, 2021 with its Plant-Based Complete Nutrition products for Toddlers.
“Entering Walmart.com is a highly significant milestone for the Company,” said Hamutal Yitzhak, CEO and Co-Founder of Else Nutrition. “The sheer size of Walmart.com will allow us to reach thousands of new families and enable us to scale significantly over the next 3 years,” she added.
According to eMarketer, Walmart’s U.S. e-commerce sales prior to the pandemic were $30 billion and are projected to hit over $64 billion by the end of 2021.
Walmart.com’s traffic was much higher the past year than pre-pandemic levels. Online shopping, particularly in the grocery and FMCG segment (Fast Moving Consumer Goods), has undergone a surge in popularity due to the pandemic. Walmart was the largest United States grocery retailer in 2019 with 65 percent of Walmart's US$510.329 billion sales coming from U.S. operations.
About Else Nutrition Holdings Inc.
Else Nutrition GH Ltd. is an Israel-based food and nutrition company focused on developing innovative, clean and plant-based food and nutrition products for infants, toddlers, children, and adults. Its revolutionary, plant-based, non-soy, formula is a clean-ingredient alternative to dairy-based formula. Else Nutrition (formerly INDI) won the "2017 Best Health and Diet Solutions" award at the Global Food Innovation Summit in Milan. Else Plant-Based Complete Nutrition for Toddlers was recently ranked as the #1 Top seller in the baby and toddler formula category on Amazon. The holding company, Else Nutrition Holdings Inc., is a publicly traded company, listed as TSX Venture Exchange under the trading symbol BABY and is quoted on the US OTC Markets QX board under the trading symbol BABYF and on the Frankfurt Exchange under the symbol 0YL. Else's Executives includes leaders hailing from leading infant nutrition companies. Many of Else advisory board members had past executive roles in companies such as Mead Johnson, Abbott Nutrition, Plum Organics and leading infant nutrition Societies, and some of them currently serve in different roles in leading medical centers and academic institutes such as Boston Children's Hospital, Pediatrics at Harvard Medical School, USA, Tel Aviv University, Schneider Children's Medical Center of Israel, Rambam Medical Center and Technion, Israel and University Hospital Brussels, Belgium.
<<<
>>> Lightwave Logic Receives New U.S. Patent on Improved Integrated Photonics Architectures
Yahoo Finance
August 9, 2021
https://finance.yahoo.com/news/lightwave-logic-receives-u-patent-123100265.html
Long-Awaited Technological Breakthrough to Improve Performance, Aid High-Volume Production
ENGLEWOOD, Colo., Aug. 9, 2021 /PRNewswire/ -- Lightwave Logic, Inc. (OTCQX: LWLG), a technology platform company leveraging its proprietary electro-optic polymers to transmit data at higher speeds with less power, today announced the receipt of a U.S. patent on a new invention that enables enhanced optical routing architectures for polymer-based integrated photonics that can be scaled with partner foundries.
The new patent - U.S. Patent number 11,067,748 and entitled "Guide Transition Device and Method" – will enable innovative, highly scalable optical routing architectures for integrated photonic platforms. The patent provides novel optical waveguide transition designs using two planes of optical waveguides that are expected to be critical for optical signal routing and optical switching, opening the opportunity for high speed, energy efficient electro-optic polymers to be implemented into foundry PDKs (process development kits) to improve the performance of integrated photonic circuits.
"This exciting new patent not only turbocharges our integrated photonics platform in general, it is a powerful architectural routing patent that discloses how optical signals can be routed in two optical planes from light generation on-chip to light coupling off-chip," said Dr. Michael Lebby, Chief Executive Officer of Lightwave Logic. "This breakthrough technology opens the door for advanced integrated photonics architectural design – something the industry has been long waiting for.
"The simplicity of the design is ideal for production in foundries, best positioning Lightwave Logic to enable increased data traffic on the internet while using less power – powering the data-hungry lifestyle of today's internet users," concluded Lebby.
About Lightwave Logic, Inc.
Lightwave Logic, Inc. (OTCQX: LWLG) is developing a platform leveraging its proprietary engineered electro-optic (EO) polymers to transmit data at higher speeds with less power. The company's high-activity and high-stability organic polymers allow Lightwave Logic to create next-generation photonic EO devices, which convert data from electrical signals into optical signals, for applications in data communications and telecommunications markets. For more information, please visit the company's website at lightwavelogic.com.
<<<
>>> Else Nutrition to Launch on Kroger-owned online platforms with Plant-Based Toddler Nutrition Products by Q4 2021
Else Nutrition Holdings Inc.
August 9, 2021
https://finance.yahoo.com/news/else-nutrition-launch-kroger-owned-110000173.html
Else readying for distribution at online platforms of Nation’s Leading Grocery Retail Chain
VANCOUVER, British Columbia, Aug. 09, 2021 (GLOBE NEWSWIRE) -- ELSE NUTRITION HOLDINGS INC. (BABY.V) (BABYF) (0YL.F) ("Else" or the "Company") the plant-based baby, toddler and children nutrition company, announces that it will be expanding into owned online marketplaces by Q4, 2021 with its Plant-Based Complete Nutrition products for Toddlers. The expansion also will place else at Kroger-owned Vitacost.com, an E-commerce leader in the healthy/organic foods space.
“Being a part of Kroger’s E-commerce platforms mark a major step forward for our online growth strategy,” said Hamutal Yitzhak, CEO and Co-Founder of Else Nutrition. “Kroger’s large on-line presence as a grocery leader, will significantly increase the accessibility of our clean label, whole food-based early nutrition products for thousands of families nationwide,” she added.
Else Nutrition is currently onboarding with Kroger Ship (of the Kroger Company), with plans to ship to Kroger customers through the Kroger.com and Vitacost.com grocery websites. Kroger Ship enables U.S. consumers the benefits of big box shopping from the comfort of your own home. Consumers can buy in bulk, browse a wide selection of products, and get access to exclusive savings.
Kroger, the nation’s largest grocery chain, saw its e-commerce sales jump by 79% in 2020, according to eMarketer, with $11.18 billion in digital sales. Riding the success of its ongoing investments in e-commerce and powered by a COVID-19 surge in online grocery sales, The Kroger Co. entered eMarketer’s annual list of Top 10 U.S. Retail E-Commerce Companies.
About Else Nutrition Holdings Inc.
Else Nutrition GH Ltd. is an Israel-based food and nutrition company focused on developing innovative, clean and plant-based food and nutrition products for infants, toddlers, children, and adults. Its revolutionary, plant-based, non-soy, formula is a clean-ingredient alternative to dairy-based formula. Else Nutrition (formerly INDI) won the "2017 Best Health and Diet Solutions" award at the Global Food Innovation Summit in Milan. Else Plant-Based Complete Nutrition for Toddlers was recently ranked as the #1 Top seller in the baby and toddler formula category on Amazon. The holding company, Else Nutrition Holdings Inc., is a publicly traded company, listed as TSX Venture Exchange under the trading symbol BABY and is quoted on the US OTC Markets QX board under the trading symbol BABYF and on the Frankfurt Exchange under the symbol 0YL. Else's Executives includes leaders hailing from leading infant nutrition companies. Many of Else advisory board members had past executive roles in companies such as Mead Johnson, Abbott Nutrition, Plum Organics and leading infant nutrition Societies, and some of them currently serve in different roles in leading medical centers and academic institutes such as Boston Children's Hospital, Pediatrics at Harvard Medical School, USA, Tel Aviv University, Schneider Children's Medical Center of Israel, Rambam Medical Center and Technion, Israel and University Hospital Brussels, Belgium.
<<<
>>> NioCorp Developments Responds to Market Activity
Yahoo Finance
June 29, 2021
https://finance.yahoo.com/news/niocorp-developments-responds-market-activity-163700824.html
CENTENNIAL, Colo., June 29, 2021 /PRNewswire/ -- At the request of IIROC ("Investment Industry Regulatory Organization of Canada"), NioCorp Developments Ltd. ("NioCorp" or the "Company") (TSX:NB) (OTCQX:NIOBF) wishes to confirm that it is not aware of any material, undisclosed information related to the Company that would account for the recent increase in the market price and level of trading volume of its common shares.
Metallurgical Update
In separate news, NioCorp is pleased to report that its metallurgical testing program continues to show excellent progress in several current areas of focus.
Ongoing testing of Elk Creek Project ("Project") ore using High-Pressure Grinding Rolls ("HPGR") technology continues to show promising results. HPGR technology is an energy efficient and low-emission alternative for reducing the size of the ore to enable the recovery of niobium, scandium, titanium, and potential rare earth products. The use of HPGR in the Project reinforces the Company's commitment to the environment and design for a sustainable operation. The testing, conducted at the Natural Resources Research Institute ("NRRI") of the University of Minnesota-Duluth, in partnership with Weir Minerals, is expected to culminate in the preparation of a 3-metric tonne metallurgical sample to be used for flowsheet optimization and rare earth recovery studies.
NioCorp's metallurgical consulting partner, L3 Process Developments, has completed initial testwork and studies related to flowsheet optimization and rare earth recovery for the Project's planned surface processing facility. The Company continues to evaluate the results of this work as part of the overall effort to determine the economics around adding rare earth recovery to the project's flowsheet.
Work is expected to commence shortly on the collection of additional historic drill core samples and the submittal of those samples for rare earth analysis to fill in gaps in coverage for the rare earths in the Company's drill hole database.
The Company has completed an internal study of the markets for rare earth products, focusing on the potential growth of those markets driven by the anticipated demand for the magnetic rare earths (Neodymium, Praseodymium, Terbium, Dysprosium) and the resulting long-term expectations related to pricing.
Qualified Persons: Scott Honan, M.Sc., SME-RM, COO of NioCorp Developments Ltd., a Qualified Person as defined by National Instrument 43-101, has reviewed and approved the technical information contained in the news release.
<<<
York Water - >>> 7 Water Stocks to Buy to Bank on Our Most Precious Resource
Investor Place
Josh Enomoto
August 6, 2021
https://finance.yahoo.com/news/7-water-stocks-buy-bank-165031612.html
Hands down, water is the most valuable commodity on Earth. But with a prolonged drought sending reservoir levels at Lake Mead to dangerous lows, many expect the U.S. government to soon declare a water shortage there. As climate change impacts this essential resource, investors should look into water stocks from companies that offer consistent service and intriguing solutions.
As Bloomberg recently reported, the Lake Mead reservoir — where the world-famous Hoover Dam is located — “is part of a broader network of natural and artificial aqueducts and dams that supplies water to 40 million people and homes, farms, manufacturers and businesses across several states, tribal lands and parts of Mexico.”
“Lights stay on in Phoenix, Tucson, Las Vegas, San Diego, Los Angeles and other Southwestern cities because Hoover Dam hydropower helps generate the region’s electricity,” the article continues. The economic firepower of these cities alone is more than enough to require a national solution.
Although presumably most folks have gotten the message by now, a solution isn’t as easy as everyone pitching in to conserve this precious resource. Here’s the deal: “Dry, sizzling summers and warmer winters that restrict water supplies may now be the norm, courtesy of a permanently altered climate.” Unfortunately, we may have to learn to live with less when it comes to water.
Out of sheer necessity, affected regions are exploring groundbreaking (but expensive) technologies like desalination — turning saltwater into drinkable water — as a stopgap. These specialists, along with companies in the water treatment space, will probably see their equity value rise. Here are seven water stocks to put on your radar:
York Water (NASDAQ:YORW)
Essential Utilities (NYSE:WTRG)
Global Water Resources (NASDAQ:GWRS)
Xylem (NYSE:XYL)
Danaher (NYSE:DHR)
Veolia (OTCMKTS:VEOEY)
Acciona (OTCMKTS:ACXIF)
Despite the overwhelming need for this irreplaceable resource, nothing in the market is a sure thing. With so much attention still on speculative trades, water stocks may encounter choppiness. But as long as you invest with a long-term outlook, you’ll probably win out in the end.
Water Stocks: York Water (YORW)
When I write about dividend plays, I usually try to fit in York Water. An investor-owned public utility firm based in Pennsylvania, the company was founded in 1816 by a group of local entrepreneurs who sought access to water to protect against fire-related threats.
In modern times, York Water “supplies nearly 20 million gallons of water every day and has more than 71,000 residential, commercial, and industrial customers.” The company has the distinct honor of being the oldest investor-owned utility in the nation. It also holds the record for the longest consecutive dividend streak, which started in 1816.
While I don’t want to jinx anything, I highly doubt that York Water is going to give up its record-holding status. Can you imagine being the management team responsible for breaking a 200-year-plus dividend streak? Just from a stability and security standpoint, YORW is well worth considering if you want to build a position in water stocks.
Essential Utilities (WTRG)
Another utility firm based in Pennsylvania, Essential Utilities covers regions in Ohio, North Carolina, Illinois, Texas, New Jersey, Indiana, Virginia and of course its home market. It specializes in drinking water and wastewater treatment infrastructure and services. Essential Utilities will likely see rising demand as climate change forces a rude awakening among American consumers.
According to Columbia Climate School, several factors related to a changing climate could have a negative impact on our water. For instance, “Warmer air can hold more moisture than cool air. As a result, in a warmer world, the air will suck up more water from oceans, lakes, soil and plants. The drier conditions this air leaves behind could negatively affect drinking water supplies and agriculture.”
Now, we’re probably not going to see a Mad Max scenario where people fight for plastic water battles. Instead, the change will likely be much more mundane. Life will look normal, except that everyone will be paying higher prices for water. And with this precious resource, everyone must pay.
As we move closer to this unfortunate reality, WTRG shares and other water stocks may see a boost from the expected rise in demand.
Water Stocks: Global Water Resources (GWRS)
If you talk to 100 Americans about climate change, you’re invariably going to find a few who aren’t interested (to say the least) in the environment or sustainability. Well, as with anything in life, every action has a reaction. For every person or company that vehemently opposes sustainability measures, there’s another that passionately supports them.
Global Water Resources is in the latter category, and that’s most evidenced by its core business divisions. On paper, it provides water, wastewater and recycled water utility services. The latter is an area of particular interest.
According to the company’s website, “Recycled water is what we produce when we treat and purify wastewater. We distribute recycled water throughout the communities we serve in a separate system of pipes. We use recycled water for a variety of outdoor uses.”
Global Water calls its approach, “Total Water Management.” It controls the entire cycle from drinking water to wastewater. As the company put it, its system “protects supplies in areas where water is scarce, making supplies available for additional growth and long-term sustainability.” It looks like sustainability advocates like Global Water have the right idea.
Xylem (XYL)
Billed as a large American water technology provider, Xylem offers solutions for public utility, residential, commercial, agricultural and industrial needs. If you take a look at its website, though, you’ll quickly discover that no single sentence could do the company justice. If I had to try, I’d say that Xylem is a one-stop-shop for any water-based challenge.
Xylem offers a decision intelligence platform to help enterprises make the best use of water. Under this umbrella, the company provides solutions such as its trademarked BLU-X Wastewater Network Optimization, a system that “helps utilities optimize networks and operations at significantly lower cost.”
For me, XYL stock is compelling because of its underlying agriculture products and irrigation systems. As the New York Times detailed in June 2021, California farmers in particular are making drastic choices about their businesses because of declining water levels. To help remedy this situation, companies like Xylem will be called into action.
It’s no wonder, then, that XYL stock is one of the top performers among water stocks. Its shares are up 26% year-to-date (YTD) and still going strong.
Water Stocks: Danaher (DHR)
Based in Washington, D.C., Danaher is a diversified conglomerate. Designing, manufacturing and marketing professional, medical, industrial and commercial products and services, Danaher has its hands in multiple endeavors. Thus, it’s no surprise that the science and technology innovator has a few things to say about water.
Under the Danaher Water Platform, the namesake corporation features a diverse portfolio of water quality optimization companies. These groups help reshape how everyday individuals approach the precious resource. Essentially, by leveraging Danaher’s complete water cycle solution, no drop goes unaccounted for.
Starting from the source, Danaher directs water resources to either drinking water plants for consumer distribution or to industrial channels. Following industrial usage and collection from consumers, wastewater treatment facilities clean the resource for later integration with the environment. And don’t worry, the arrows in this supply chain chart ultimately only flow in one direction.
For investors, Danaher is an intriguing water stock because the underlying company offers multiple revenue streams across various industries. It’s a hot performer as a result, up more than 35% YTD.
Veolia (VEOEY)
Perhaps the cruelest irony in the ongoing debate over climate change is that water covers approximately 71% of the earth’s surface. Therefore, an obvious solution to the problem is to take water from the ocean and make it potable by clean out the salt and other gunk. Sure enough, there are a few publicly traded companies specializing in this process called desalination.
One of them is Veolia, a French transnational company focused on water management, waste management and energy services. Under these broad categories, Veolia has a seawater desalination division.
The organization has been at it for a while, with “more than 40 years of experience, technologies and knowledge in desalination.” Veolia has built more than 1,950 reverse osmosis desalination plants and systems in 85 countries during that time. The company claims that its facilities produce more than 6.75 million cubic meters of freshwater daily for municipal and industrial needs.
It may sound too good to be true, but VEOEY stock is up nearly 30% YTD, so investors clearly love it. However, per MIT Technology Review, desalination (especially via reverse osmosis) is expensive due to large electricity requirements.
Water Stocks: Acciona (ACXIF)
If you want another option in the desalination game, you may want to check out Acciona, a Spanish multinational conglomerate dedicated to the development and management of infrastructure and renewable energy. As a diversified corporation focusing on sustainable solutions, it is part of a worldwide effort to address climate change.
Like its French competitor, Acciona prides itself on being a world leader in desalination plant construction with acumen in reverse osmosis technology. More importantly, the company has an extensive operational track record. For example, in May of this year, management announced that it will build and operate a desalination plant in Los Cabos, Mexico.
Further, in late December 2020, Acciona announced that the Saline Water Conversion Corporation awarded it and its partner RTCC a $348 million contract to design and build a desalination plant. The site, known as Shuqaiq 1, will be located on the Red Sea coast in Saudi Arabia. The agreement demonstrates how much confidence the international business community has in Acciona’s expertise.
While exciting, it’s also worth emphasizing that desalination is a work in progress. For it to truly become viable, the process must come down in price. Still, if you’re a patient investor, AXCIF stock might be worth a look or a buy with speculation funds.
<<<
>>> Winmark Corporation Announces Second Quarter Results
Yahoo Finance
July 14, 2021
https://finance.yahoo.com/news/winmark-corporation-announces-second-quarter-153400492.html
MINNEAPOLIS, July 14, 2021--(BUSINESS WIRE)--Winmark Corporation (Nasdaq: WINA) announced today net income for the quarter ended June 26, 2021 of $8,937,300 or $2.33 per share diluted compared to net income of $5,055,200 or $1.33 per share diluted in 2020. For the six months ended June 26, 2021, net income was $18,248,400 or $4.74 per share diluted compared to net income of $12,372,200 or $3.21 per share diluted for the same period last year.
"Our business model is thriving in the current retail environment," commented Brett D. Heffes, Chairman and Chief Executive Officer.
Winmark, the Resale CompanyTM, is a nationally recognized franchising business focused on sustainability and small business formation. We champion and guide entrepreneurs interested in operating one of our award winning resale franchises: Plato’s Closet®, Once Upon A Child®, Play It Again Sports®, Style Encore® and Music Go Round®. At June 26, 2021, there were 1,266 franchises in operation and over 2,000 available territories. An additional 36 franchises have been awarded but are not open.
<<<
>>> Magic Software Enterprises Ltd. (MGIC) provides proprietary application development, business process integration, vertical software solutions, and information technologies (IT) outsourcing software services in Israel and internationally. The company's Software Services segment develops, markets, sells, and supports application platform, software applications, and business and process integration solutions and related services. Its IT Professional Services segment offers IT services in the areas of infrastructure design and delivery, application development, technology planning and implementation services, communications services and solutions, and supplemental outsourcing services. The company offers proprietary application platforms, such as Magic xpa for developing and deploying business applications; AppBuilder for building, deploying, and maintaining high-end and mainframe-grade business applications; Magic xpi for application integration; Magic xpc, a hybrid integration platform as a service; Magic SmartUX, a mobile development application platform; and FactoryEye for virtualization of production data. It also provides vertical software solutions comprising Clicks, a software solution for healthcare providers; Leap, a software solution for business support systems; Hermes Solution, a packaged software solution for managing air cargo ground handling; HR Pulse, a customized single-tenant software as a service tool; and MBS Solution, a proprietary system for managing TV broadcast management. In addition, the company provides software maintenance, support, training, and consulting services. It serves oil and gas, telecommunications, financial, healthcare, and industrial sectors; and public institutions and international agencies. The company was formerly known as Mashov Software Export (1983) Ltd. and changed its name to Magic Software Enterprises Ltd. in 1991. Magic Software Enterprises Ltd. was incorporated in 1983 and is headquartered in Or Yehuda, Israel.
<<<
>>> Byrna Technologies Introduces its Revolutionary Byrna Eco-Kinetic Round
Yahoo Finance
August 2, 2021
https://finance.yahoo.com/news/byrna-technologies-introduces-revolutionary-byrna-132800291.html
- the First Truly Environmentally Friendly .68 Caliber Non-Lethal Round
ANDOVER, Mass., Aug. 2, 2021 /PRNewswire/ -- Byrna Technologies Inc. (NASDAQ: BYRN) (CSE: BYRN) ("Byrna" or "the Company") today announced the introduction of its new .68 caliber projectile, the Byrna Eco-Kinetic round. The Eco-Kinetic round became available for pre-order on the Byrna website (www.byrna.com) starting on August 1.
The Byrna Eco-Kinetic round is a revolutionary .68 caliber non-lethal projectile designed to replace both kinetic and inert practice rounds. At only 25 cents per round (in the 400-count container), Byrna's Eco-Kinetic round is one of the lowest priced non-lethal rounds on the market. More importantly, the Eco-Kinetic is the first truly environmentally friendly .68 caliber non-lethal projectile. This water-soluble round dissolves completely when left out in the elements. The Byrna Eco-Kinetic round is designed to "make your mark without leaving a trace," which is the tagline for this product.
Byrna's Eco-Kinetic projectile also features Byrna's VI (visual impact) technology producing a "report" when it strikes a hard surface. By producing a small cloud and leaving a visible mark indicating where the round strikes the target, users can see the exact location of their shot (in the same way they can with the more expensive inert rounds). The very low purchase price of the Eco-Kinetic round, coupled with Byrna's VI technology and the fact that this is an environmentally friendly projectile, makes Byrna's Eco-Kinetic round ideal for target practice and recreational use. Byrna intends to feature the Eco-Kinetic round prominently in its upcoming recreational and family-fun marketing campaigns. The Eco-Kinetic round can also be used to replace the "Byrna Kinetic" round for self-defense as they both deliver the same amount of joule energy.
Byrna will continue to offer its inert rounds under the "Byrna Training" label. These rounds, which are designed to mimic the cloud produced by "Byrna Pepper" and "Byrna Max", are used primarily by law enforcement during training so that they can see the dispersion of the chemical irritant cloud. Similarly, Byrna will continue to offer its "Byrna Kinetic" round as a self-defense and glass breaking round. The "Byrna Kinetic" round, which can break a car window and uses pain compliance to stop an assailant, has proven to be very popular with both the private security and law enforcement communities.
"Environmental sustainability is extremely important to us at Byrna and it was the driving force behind the development of our Eco-Kinetic round," stated Bryan Ganz, CEO of Byrna Technologies. "We believe that our Eco-Kinetic round will become our best-selling projectile as consumers embrace the recreational use of the Byrna, honing their shooting skills in their backyards while having fun with friends and family. Importantly, by increasing engagement, Byrna owners will become more proficient with their devices and more comfortable in the event they need to deploy their Byrna in a real-world self-defense situation. Moreover, this increased consumer engagement should help us further leverage Byrna's razor/razorblade model."
About Byrna Technologies Inc.
Byrna is a technology company, specializing in the development, manufacture, and sale of innovative non-lethal personal security solutions. For more information on the Company, please visit the corporate website here or the Company's investor relations site here. The Company is the manufacturer of the Byrna® HD personal security device, a state of the art handheld CO2 powered launcher designed to provide a non-lethal alternative to a firearm for the consumer, private security, and law enforcement markets.
<<<
>>> RiceBran Technologies Reports 28% Increase in Second Quarter Revenue
Yahoo Finance
August 3, 2021
https://finance.yahoo.com/news/ricebran-technologies-reports-28-increase-200600352.html
Turnaround Continues with Year-Over-Year Improvement in All Key Financial Measures
Strong Growth in SRB Derivatives Sales to be Bolstered by New Products and New Distributor
Management Affirms Outlook for Continued Improvement in Operating and Financial Results
TOMBALL, TX / ACCESSWIRE / August 3, 2021 / RiceBran Technologies (NASDAQ:RIBT), a global leader in the development and production of critical nutritional and functional ingredients derived from small and ancient grains for the healthy food, nutraceutical, pet care and animal feed markets, today announced financial results for the three and six months ended June 30, 2021.
Second Quarter 2021 Operating Highlights
"A 28% year-over-year increase in revenues and a 70% reduction in adjusted EBITDA losses, underpinned by improvements at every facility, signal the successful turnaround of our operations," said RiceBran's Executive Chairman Peter Bradley. "Continued strong demand for our SRB derivatives and the announcement today of our agreement with AIDP, a leading supplier to the supplement and nutraceutical markets, further validates our strategic shift to higher value-add specialty ingredients. With this important new relationship, an increased supply of raw materials, enhanced production capabilities, and the introduction of new products, we remain confident in our ability to generate continued growth as we transition to sustainable profitability."
Significant year-over-year improvement in financial results. Total revenue was $7.6 million in the second quarter of 2021, a 28% increase from the second quarter of 2020. Gross profit was $153,000 in the second quarter of 2021, compared to a gross loss of $1.2 million a year ago, and with a 16% year-over-year reduction in SG&A to $1.9 million, and the absence of last year's asset disposal charges, operating losses in the quarter decreased to $1.8 million from $3.8 million a year ago, and net losses fell to $1.9 million from $3.9 million. Because of these improvements, adjusted EBITDA losses (non-GAAP) narrowed by $2.0 million year-over-year to $828,000 in the second quarter of 2021, from $2.9 million in the second quarter of 2020.
AIDP agreement to expand market reach for SRB derivatives. With a renewed focus, sales of high value-add SRB derivatives grew over 30% year-over-year in the second quarter and have nearly doubled year-to-date. Announced today, RiceBran has formed a distribution agreement for these products with AIDP Inc. ("AIDP"), one of the leading suppliers of specialty ingredients into the supplement and nutraceutical markets. This relationship should expand the Company's market reach for SRB derivatives significantly and drive continued strong revenue growth by supporting the full commercialization of these products.
Expanding specialty ingredient focus with new product launches. RiceBran launched two new products in the second quarter of 2021, new versions of California-sourced SRB for use in powdered beverages, tablets, and capsules to complement our existing line of SRB derivatives for these applications, and a line of organic micronized rice hulls for flow aid and emulsion applications. Mix in the second half of 2021 should be positively impacted by higher levels of organic feedstock, and new formulations of SRB and SRB derivatives are in development. Success with these initiatives should support further product launches, continued revenue growth, and improved margins.
New sales initiatives expected to further enhance results. During the quarter, RiceBran transitioned its sales team to a business-line focus with three key areas of emphasis; Value Added (SRB derivatives), Core-SRB, and Milled Grains. Each of these three groups is now headed by a dedicated Sales leader and supported by its own integrated team of customer service and quality assurance professionals. RiceBran expects this structure will lead to continued sales growth, higher levels of productivity, and improved margins, pushing the company forward in its transition to positive adjusted EBITDA (non-GAAP).
Golden Ridge and MGI milling operation generate over 50% growth. Golden Ridge and MGI both generated over 50% year-over-year revenue growth in the second quarter of 2021. This was accomplished despite seasonal headwinds and a volatile raw material market, due to improved operations and a successful initiative to grow and diversify the customer base for both facilities. Golden Ridge's operating performance continues to improve, and the facility's bran room is now up and running, while MGI has commenced milling of specialty barley varieties and is benefiting from a growing customer base.
Second Quarter 2021 Financial Highlights
"Our turnaround is on track with significant year-over-year improvements in all key financial measures," RiceBran's CFO Todd Mitchell commented. "Revenue growth was supported by strong demand for SRB derivatives, and higher sales at both Golden Ridge and MGI despite seasonal pressures, volatility in raw materials costs, and some supply chain disruptions. We reduced adjusted EBITDA losses (non-GAAP) by over 70% from a year ago due to higher revenues, improvements in operation at every facility, and a 16% year-over-year reduction in SG&A. We expect further improvement in profitability in the second half of 2021, and we remain well-positioned to transition to positive adjusted EBITDA (non-GAAP) in the coming quarters."
Total revenue grew 28% year-over-year on higher sales of SRB derivatives and milled grains. Total revenue grew by $1.7 million to $7.6 million, compared to $5.9 million in the second quarter of 2020. Sales from all major business lines were up year-over-year, but the 28% increase in total revenue was principally driven by higher sales of SRB derivatives and a 50%-plus increase in quarterly revenues from both Golden Ridge and MGI. Total revenue was down by $1.0 million from $8.6 million in the first quarter of 2021 due to a seasonal pull back at Golden Ridge and MGI as the market prepared to transition from one crop year to the next.
Gross profit was $153,000, up $1.4 million from gross losses of $1.2 million a year ago. Year-over-year improvement in gross profit was driven by lower losses at Golden Ridge, improved profitability for the company's SRB businesses, both core-SRB and SRB derivatives, and growth and margin expansion at MGI. Gross profit declined from $672,000 in the first quarter of 2021 due to lower revenues, higher raw material costs from new supply contracts that will enhance our manufacturing footprint, and a seasonal narrowing of spreads in some milled grains we sell, exacerbated by negative weather trends.
Quarterly SG&A was down 26% before the impact of last-year's asset disposals. Quarterly SG&A declined 16% year-over-year to $1.9 million in the second quarter of 2021 from $2.6 million a year ago, including $308,000 in asset disposals last year. SG&A was up $192,000 from $1.7 million in the first quarter due to higher compensation expenses and increases in overall insurance rates. Combined with the year-over-year improvement in gross profit, quarterly operating losses narrowed to $1.8 million from $3.9 million a year ago, and net losses fell to $1.9 million from $3.9 million.
Adjusted EBITDA (non-GAAP) losses drop $2.1 million from $2.9 million a year ago. Adjusted EBITDA losses (non-GAAP) narrowed to $828,000 in the second quarter of 2021, down from losses of $2.9 million a year ago due to higher revenue, the transition to positive gross profit, and a 16% decline in SG&A. Adjusted EBITDA losses (non-GAAP) increased from $159,000 in the first quarter of 2021 due to lower revenue and gross profit and higher SG&A. With higher revenues and more stable raw material costs, quarterly adjusted EBITDA losses should improve in the third and fourth quarters from second quarter levels.
Balance Sheet is strong with $4 million in total cash and net debt (non-GAAP) of $198,000. The Company ended the second quarter of 2021 with $4.0 million in cash, down from $5.4 million at the end of the first quarter. The decline was driven by higher overall operating losses, a reduction in factored borrowing and commodities payable due to seasonal deceleration at Golden Ridge, and the timing of expenses and insurance payments for hurricane repairs to Lake Charles. Operating losses are expected to improve in the second half of 2021, and the Company believes it has sufficient reserves to operate to profitability.
Full Year 2021 Outlook and Objectives
"With our new relationship with AIDP, the enhanced focus of our sales team, and beginning of our product expansion, we accomplished what we set out to do in the quarter," Mr. Bradley added. "We were pleased with the significant year-over-year improvement in financial results in the second quarter, and initial trends show some signs of acceleration in the third quarter as we move towards new crop. With higher revenues, quarterly adjusted EBITDA losses are expected to improve in the third and fourth quarters from second quarter levels, although reaching our goal of positive adjusted EBITDA before 2021 year-end may prove challenging. However, with expanded distribution, the launch of new products, and a more focus sales effort, we remain confident that we are on the path to sustainable growth and positive adjusted EBITDA."
Conference Call Information
RiceBran Technologies will host a conference call today, Tuesday, August 3, at 4:30 p.m. Eastern Time to discuss these results. The call information is as follows:
Date: August 3, 2021
Time: 4:30 p.m. Eastern Standard Time
Toll Free Dial-in number for US/Canada: 844-369-8770
Dial-In number for international callers: 862-298-0840
Webcast: https://www.ricebrantech.com/investors
Following the conclusion of the live call, a replay of the webcast will be available on the Investor Relations section of the Company's website for at least 90 days. A telephonic replay of the conference call will also be available from 7 p.m. EST on August 3, 2021 until 11:59 p.m. EST on August 17, 2021 by dialing 877-481-4010 (United States) or 919-882-2331 (international) and using the passcode 42240.
About RiceBran Technologies
RiceBran Technologies is a specialty ingredient company focused on the development, production, and marketing of products derived from traditional and ancient small grains. Notably, we are global leader in the production and marketing of stabilized rice bran (SRB), and high value-added derivative products derived from SRB, as well as a processor of rice, rice co-products, and barley and oat products. We create and produce products utilizing proprietary processes to deliver improved nutrition, ease of use, and extended shelf-life, while addressing consumer demand for all natural, non-GMO and organic products. The target markets for our products include food and animal nutrition manufacturers and retailers, as well as specialty food, functional food and nutritional supplement manufacturers and retailers, both domestically and internationally. More information can be found in the Company's filings with the SEC and by visiting our website at http://www.ricebrantech.com.
<<<
>>> Lightwave Logic Announces Breakthrough Thermal Design for Use in Ultra-High-Speed Polymers
Yahoo Finance
August 4, 2021
https://finance.yahoo.com/news/lightwave-logic-announces-breakthrough-thermal-123100786.html
Enhanced Thermal Properties Enable the Speed, Flexibility and Stability Needed for High-Volume Silicon Foundry Processes
ENGLEWOOD, Colo., Aug. 4, 2021 /PRNewswire/ -- Lightwave Logic, Inc. (OTCQX: LWLG), a technology platform company leveraging its proprietary electro-optic polymers to transmit data at higher speeds with less power, today announced that it has developed improved thermal design properties for electro-optic polymers used in its Polymer Plus™ and Polymer Slot™ modulators, enabling the speed, flexibility and stability needed for high-volume silicon foundry processes.
"High-temperature thermal performance is one measure of robustness and a key metric commonly discussed with potential customers for fiber optic datacenter and telecommunications applications," said Dr. Michael Lebby, Chief Executive Officer of Lightwave Logic. "Our in-house team successfully created a 2x improvement in r33, while allowing higher stability during poling and post-poling. This provides not only better thermal performance, but also enables greater design flexibility in high-volume silicon foundry PDK (process development kit) processes. This is critical as we seek to make our technology ubiquitous throughout the marketplace.
"Preliminary results suggest that Lightwave Logic's recently developed electro-optic polymer material, designed based on customer input, displays unrivaled thermal performance tolerance as compared to any commercial solution in use today. We look forward to receiving feedback on this exciting new material from our potential customers," concluded Lebby.
About Lightwave Logic, Inc.
Lightwave Logic, Inc. (OTCQX: LWLG) is developing a platform leveraging its proprietary engineered electro-optic (EO) polymers to transmit data at higher speeds with less power. The Company's high-activity and high-stability organic polymers allow Lightwave Logic to create next-generation photonic EO devices, which convert data from electrical signals into optical signals, for applications in data communications and telecommunications markets. For more information, please visit the Company's website at lightwavelogic.com.
<<<
>>> Else Launches Clinical Study with Children’s Hospital Colorado and Denver School of Medicine to Validate Growth Benefits of Else’s Plant-Based Nutrition
Yahoo Finance
Else Nutrition Holdings Inc.
July 29, 2021
https://finance.yahoo.com/news/else-launches-clinical-study-children-110000492.html
Study to compare 4-month period consumption of Else Plant-Based Toddler Nutrition vs. Consumption of Cow Milk-Based Formula
VANCOUVER, British Columbia, July 29, 2021 (GLOBE NEWSWIRE) -- ELSE NUTRITION HOLDINGS INC. (BABY.V) (BABYF) (0YL.F) ("Else" or the "Company") the plant-based baby, toddler and children nutrition company, announces the launch of a clinical study aimed at validating its toddler and kids products support growth benefits in healthy young children vs. cow-milk-based formula. The study will be led be Prof. David Fleischer, and Prof. Carina Venter from the Allergy and Immunology Center, Children's Hospital Colorado and University of Colorado Denver School of Medicine. Prof. David Fleischer, and Prof. Carina Venter are leading research in the field of food allergy prevention and working with children with food allergies.
This study is part of the overall efforts to establish the scientific basis for the safety and tolerance of Else Nutrition products. It will follow healthy toddlers for four months, comparing growth and wellness versus those consuming a commercial cow milk -based toddler product.
“This is an exciting development for the brand, and we are confident that it will further validate the efficacy of our whole food-based nutrition products for early childhood,” said Hamutal Yitzhak, CEO and Co-Founder of Else Nutrition. “Thousands of families across North America have already taken to Else products, and we’ve been hearing tremendous feedback, including real life-improving cases. This study will only serve as further validation, and can serve us in our Medical Marketing efforts,” she added.
About Else Nutrition Holdings Inc.
Else Nutrition GH Ltd. is an Israel-based food and nutrition company focused on developing innovative, clean and plant-based food and nutrition products for infants, toddlers, children, and adults. Its revolutionary, plant-based, non-soy, formula is a clean-ingredient alternative to dairy-based formula. Else Nutrition (formerly INDI) won the "2017 Best Health and Diet Solutions" award at the Global Food Innovation Summit in Milan. Else Plant-Based Complete Nutrition for Toddlers was recently ranked as the #1 Top seller in the baby and toddler formula category on Amazon. The holding company, Else Nutrition Holdings Inc., is a publicly traded company, listed as TSX Venture Exchange under the trading symbol BABY and is quoted on the US OTC Markets QX board under the trading symbol BABYF and on the Frankfurt Exchange under the symbol 0YL. Else's Executives includes leaders hailing from leading infant nutrition companies. Many of Else advisory board members had past executive roles in companies such as Mead Johnson, Abbott Nutrition, Plum Organics and leading infant nutrition Societies, and some of them currently serve in different roles in leading medical centers and academic institutes such as Boston Children's Hospital, Pediatrics at Harvard Medical School, USA, Tel Aviv University, Schneider Children's Medical Center of Israel, Rambam Medical Center and Technion, Israel and University Hospital Brussels, Belgium.
<<<
>>> Lightwave Logic Invited to Present at 2021 European Conference on Optical Communications
Yahoo Finance
July 29, 2021
https://finance.yahoo.com/news/lightwave-logic-invited-present-2021-123100346.html
CEO Dr. Michael Lebby to Participate in World-Leading Market Focus Session on Integrated and Silicon Photonics, Further Broadening Company Awareness Amongst Tier-1 Industry Attendees
ENGLEWOOD, Colo., July 29, 2021 /PRNewswire/ -- Lightwave Logic, Inc. (OTCQX: LWLG), a technology platform company leveraging its proprietary electro-optic polymers to transmit data at higher speeds with less power, today announced that it has been invited to present as part of the 2021 European Conference on Optical Communications (ECOC), which will be held September 13-15th, 2021 in Bordeaux, France.
CEO Dr. Michael Lebby, Chairman of the ECOC Market Focus Committee, will participate in the Market Focus Session, which will include his presentation on Lightwave's implementation of electro-optic polymer modular platforms into foundry PDKs (process development kits) for mass production with global foundries, to an audience of industry experts and other industry participants. In addition, Dr. Lebby will discuss the potential impact of the company's recently issued patents, and improvements and polymer stability and reliability which are expected to improve internet speeds and reduce power usage.
"We believe that our polymer-based silicon photonic modulators can double the speed of existing devices while using less power, which is revolutionary and could forever transform internet infrastructure," said Dr. Michael Lebby, Chief Executive Officer of Lightwave Logic. "We are well positioned to scale and enable increased internet traffic, providing significant value to all internet stakeholders. I look forward to providing a technical update and continuing to position Lightwave as a clear thought leader in this space with one of the hottest topics at this tier-1 industry conference."
About Lightwave Logic, Inc.
Lightwave Logic, Inc. (OTCQX: LWLG) is developing a platform leveraging its proprietary engineered electro-optic (EO) polymers to transmit data at higher speeds with less power. The company's high-activity and high-stability organic polymers allow Lightwave Logic to create next-generation photonic EO devices, which convert data from electrical signals into optical signals, for applications in data communications and telecommunications markets. For more information, please visit the company's website at lightwavelogic.com.
<<<
>>> Nanalysis Scientific Corp. Announces $8 Million "Bought Deal" Public Offering
Yahoo Finance
July 29, 2021
https://finance.yahoo.com/news/nanalysis-scientific-corp-announces-8-120400545.html
CALGARY, AB, July 29, 2021 /CNW/ - (the "Company" or "Nanalysis"), (TSXV: NSCI) (OTCQX: NSCIF) (FRA: 1N1) is pleased to announce that it has entered into an agreement with a syndicate of underwriters led by Echelon Wealth Partners Inc. (the "Underwriters") pursuant to which the Underwriters have agreed to purchase 6,666,700 units (the "Units") from the treasury of the Company, at a price of $1.20 per Unit (the "Issue Price") and offer them to the public by way of a short form prospectus for total gross proceeds of approximately $8,000,000 (the "Offering"). Each Unit will consist of one common share of the Company (each a "Common Share") and one-half of one common share purchase warrant (each full warrant, a "Warrant" and collectively the "Warrants"). Each whole Warrant shall entitle the holder thereof to acquire one Common Share for an exercise price of C$1.70 for period 24 months following the Closing Date.
The Company has granted the Underwriters an option to purchase up to an additional 15% of the Units at the Issue Price. The Over-Allotment Option may be exercised in whole or in part to purchase Common Shares, Warrants or Units as determined by the Underwriters upon written notice to the Company at any time up to 30 days following the Closing Date (the "Over-Allotment Option").
The Company intends to use the net proceeds of the Offering for sales, marketing, research and development, acquisitions, general administrative and working capital purposes.
The Offering will be completed (i) by way of a short form prospectus of the Company to be filed in British Columbia, Alberta, and Ontario, (ii) on a private placement basis in the United States pursuant to exemptions from the registration requirements of the United States Securities Act of 1933, as amended (the "U.S. Securities Act") and (iii) outside Canada and the United States on a basis which does not require the qualification or registration of any of the Company's securities under domestic or foreign securities laws.
This news release does not constitute an offer to sell or a solicitation of an offer to sell any of securities in the United States. The securities have not been and will not be registered under the U.S. Securities Act or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.
Concurrently with the Offering the Company may conduct a non-brokered private placement for up to $5,000,000 of Units issued on the same terms as the Offering.
The Offering is expected to close on or about August 25, 2021, or such other date as the Company and the Underwriters may agree, and is subject to customary closing conditions, including the approval of the securities regulatory authorities and the TSX Venture Exchange.
About Nanalysis Scientific Corp. (TSXV: NSCI , OTCQX: NSCIF, FRA: 1N1)
Nanalysis trades on the TSX Venture Exchange (TSXV) in with ticker symbol ' NSCI ' ,Over the Counter (OTC) in under the ticker symbol ' NSCIF ', and on the Frankfurt Exchange (FRA) under the symbol ' 1N1 '.
Nanalysis is an international business focused on capitalizing its proprietary technologies in magnetic resonance (MR) that go into NMR spectrometers and magnetic resonance imaging (MRI). Nanalysis operates out of two subsidiaries, Nanalysis Corp. and RS2D S.A.S. (RS2D).
Nanalysis Corp. is an industry leader in developing and manufacturing compact MR spectrometers for laboratory and industrial markets. Its advanced 60 and 100 MHz spectrometers require no liquid helium or other cryogens. These devices are used by chemical professionals spanning a wide variety of industries, including oil and gas, chemical, mining, pharmaceutical, and biotechnology.
Through its European subsidiary RS2D, the Company's electronic boards and software are used in conventional NMR and MRI equipment and are being incorporated into next-gen MRI systems as well as miniaturized MRI devices.
<<<
Nanalysis - >>> Stonegate Capital Partners Initiates Coverage on Nanalysis Scientific Corp. (TSXV:NSCI)
Yahoo Finance
July 26, 2021
https://finance.yahoo.com/news/stonegate-capital-partners-initiates-coverage-203000391.html
DALLAS, TX / ACCESSWIRE / July 26, 2021 / Nanalysis Scientific Corp. (TSXV:NSCI): The full report can be accessed by clicking on the following link:http://stonegateinc.com/reports/NSCI.V Initiation.pdf
COMPANY DESCRIPTION
Nanalysis Scientific Corp., develops, manufactures, and sells compact nuclear magnetic resonance (NMR) spectrometers and magnetic resonance imaging (MRI) equipment. The Company has a 10-year history as a global developer and supplier of portable nuclear magnetic resonance spectrometers for the industrial instrumentation market. Its products enhance analytical capabilities in quality control, research, teachings, and industrial environments through increasing availability of high-resolution NMR testing at fractional pricing in portable benchtop tools. The Company sells its products globally and is headquartered in Calgary, Canada. Furthermore, management notes that 30% of shares are held by employees.
COMPANY SUMMARY
Unique technology platform looking to disrupt the market - Many NMR systems are large, expensive, complex, unsafe and often environmentally unfriendly. Additionally, there are many industries that have a "traditional" way of analyzing samples, based on a technique or instrument(s) that have often excluded NMR based products due to limited access to NMR systems. While the scientific instrumentation market has been transitioning slowly toward smaller, compact systems, the market remains ripe for disruption. Nanalysis, through its proprietary, innovative product lines, is addressing unmet needs of customers in a variety of applications and industries. Nanalysis product is compact, inexpensive, simple to use, as safe to operate as a laptop, and environmentally friendly.
Large market opportunity - According to SDi's 2021 Global Assessment Report, the scientific instrumentation market will exceed $69B in 2021 and is expected to grow by over 5% per year. Furthermore, about $1B is spent on NMR testing equipment. Management believes the NMR market can grow by several billion dollars per year over the next five years driven by (1) the miniaturization of the technology should expand its use in many additional laboratories leading to standardization; and (2) new, industry specific applications that in the past, did not use scientific instrumentation.
Nanalysis' products are patent protected - Importantly, Nanalysis products are patent protected and uses proprietary hardware, software, algorithms and are further secured by technology know-how and trade secrets. These protections were developed over the past 10-15 years via its innovation, customer feedback, and manufacturing experience.
Growth strategy points to further growth - The Company's strategy is focused on organic growth and supplemented with M&A. On the organic side, Nanalysis will focus on innovation of new, best-in-class products and seek additional OEM relationships to collaborate and jointly develop new analytical solutions. The M&A strategy will seek tuck-in type acquisitions of complimentary business to drive scale economics such that the whole is worth more than the sum of its parts.
Strong sales backlog - At the end of Q121, Nanalysis has a backlog of 22 units of the 100 MHz NMRs, after sales of 6 units in Q121. On the balance sheet, unearned revenue grew from $2.9M at Q420 end to $3.9M at Q121.
Valuation - Given the early ramp in revenues, we are using an EV/S multiple analysis. Based on our F22 revenue estimate, we arrive at a valuation range of CAD$1.25 to CAD$2.95, with a mid-point of CAD$2.10. See page 6 for further details.
About Stonegate Capital Partners
Stonegate Capital Partners is a Dallas-based corporate advisory firm dedicated to serving the specialized needs of small-cap public companies. Since our inception, our mission has been to find innovative, undervalued public companies for our network of leading institutional investors who seek high-quality investment opportunities.
<<<
>>> Else Broadens its Clean Plant-Based Nutrition Product Range with Nutrient Dense Super Cereals for 6 Mo+ Babies
Yahoo Finance
Else Nutrition Holdings Inc.
July 27, 2021
https://finance.yahoo.com/news/else-broadens-clean-plant-based-110000093.html
Plant-Powered nutrient dense porridge in Original, Banana and Mango Flavor Available Soon Exclusively on elsenutrition.com, Amazon.com and other retailers
VANCOUVER, British Columbia, July 27, 2021 (GLOBE NEWSWIRE) -- ELSE NUTRITION HOLDINGS INC. (BABY.V) (BABYF) (0YL.F) ("Else" or the "Company") the plant-based baby, toddler and children nutrition company, continues its mission to change the face of early childhood nutrition with sustainable, clean label, whole food-based products, with the entry into the baby food space with a line of complementary nutrition baby cereals.
The cereals are aimed to further help those families struggling with dairy intolerance, those embracing Plant-Based living, and those unwilling to accept the overly processed formulas/nutrition products currently available. The addition of this new line of products will provide a greater variety of healthy nutritional alternatives for parents.
Company is entering into a new territory for the Else brand with this current launch of complementary nutrition baby cereals, for 6 months and up. This is on the heels of the rapid entry of its original Plant-Powered Complete Nutrition for Toddlers, and the Plant-Powered Complete Nutrition Shakes for Kids, launched in June 2021. This new line complements Infant and Toddler formulas, and is also derived from organic almonds, buckwheat and tapioca, all clean, minimally processed whole ingredients that preserve their fullest macro nutritional benefits.
“This marks a key milestone for the Company as we continue on our goal towards offering a full range of clean label, plant-based nutrition for infants, toddlers and young children,” said Hamutal Yitzhak, CEO and Co-Founder of Else Nutrition. “These clean label, nutrient dense baby cereals greatly expand our offering and creates a beachhead into the extensive and growing infant nutrition market,” she added.
Infant and toddler cereal products make up close to 40% of the fast-growing U.S. Baby Food market, which was valued at $12.9 billion in 2018 and is projected to reach $17.2 billion by 2026, growing at a CAGR of 3.7% from 2019 to 2026.1
The new product line will be first available in Original, Banana and Mango Flavours with additional flavors to follow.
1https://www.alliedmarketresearch.com/us-baby-food-market.
For more information, visit: elsenutrition.com or @elsenutrition on Facebook and Instagram.
About Else Nutrition Holdings Inc.
Else Nutrition GH Ltd. is an Israel-based food and nutrition company focused on developing innovative, clean and Plant-Based food and nutrition products for infants, toddlers, children, and adults. Its revolutionary, Plant-Based, non-soy, formula is a clean-ingredient alternative to dairy-based formula. Else Nutrition (formerly INDI) won the "2017 Best Health and Diet Solutions" award at the Global Food Innovation Summit in Milan. The holding company, Else Nutrition Holdings Inc., is a publicly traded company, listed as TSX Venture Exchange under the trading symbol BABY and is quoted on the US OTC Markets QX board under the trading symbol BABYF and on the Frankfurt Exchange under the symbol 0YL. Else's Executives includes leaders hailing from leading infant nutrition companies. Many of Else advisory board members had past executive roles in companies such as Mead Johnson, Abbott Nutrition, Plum Organics and leading infant nutrition Societies, and some of them currently serve in different roles in leading medical centers and academic institutes such as Boston Children's Hospital, Pediatrics at Harvard Medical School, USA, Tel Aviv University, Schneider Children's Medical Center of Israel, Rambam Medical Center and Technion, Israel and University Hospital Brussels, Belgium.
<<<
>>> Nanalysis Acquires New York Based Software Company
Yahoo Finance
July 21, 2021
https://finance.yahoo.com/news/nanalysis-acquires-york-based-software-004500582.html
CALGARY, AB, July 21, 2021 /CNW/ - Nanalysis Scientific Corp. ("the Company", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), is pleased to announce that it has acquired 100 percent of One Moon Scientific ("OMS"), a New York based magnetic resonance software company. This acquisition opens up new industry verticals for hardware sales and allows for software licensing and SAAS revenue.
One Moon Scientific specializes in a suite of software tools to streamline and automate Magnetic Resonance ("MR") data analysis and management. Originally developed at a leading pharmaceutical company, this advanced software platform was designed from the ground up to be a powerful platform to provide routine, high-performance data processing and fill niches in MR data analysis, including machine learning and database construction/search algorithms. The founder and CEO, Bruce Johnson, will remain as a consultant and will also continue his university academic research.
Sean Krakiwsky, founder and CEO of Nanalysis said "This acquisition will allow us to evolve our revenue model to include software licensing and software as a service (SaaS). As demand continues to increase for our hardware products, management felt it was the right time to add a complete software package to our product mix. This will position us to further penetrate certain vertical markets, such as food authentication and biological diagnostic technologies."
"Joining forces with an experienced MR software leader, such as Bruce Johnson, is a critical part of our strategy to build a fully vertically integrated NMR/MRI company focused on providing industrial solutions with necessary software layers to provide, accurate, and reliable data.
"This acquisition will allow us to add important features to our current installed base and will also strengthen our position with key partners. This acquisition allows us to offer comprehensive data processing, including both AI and deep learning algorithms, on top of our world-class hardware products."
Bruce Johnson, founder and CEO of One Moon Scientific, Inc. said "This is a fantastic opportunity to ensure the long-term future of software I've been developing for over 25 years. The acquisition of One Moon Scientific, Inc. by Nanalysis will bring new developments to the software beyond our academic work in biomolecular MR and will grow the user base of these software tools that are already used by a global community."
About the Acquisition
The base consideration paid for OMS is US $625,000, of which $275,000 will be paid in cash and $350,000 will be paid through the issuance of four promissory notes. The promissory notes are convertible at the option of Nanalysis to repay the indebtedness owing under the notes by: (i) cash or ; (ii) Nanalysis shares. The former shareholders of OMS may also receive an earn-out over the three years to December 31, 2024, based on future revenue growth objectives.
The closing of this transaction is subject to several customary closing conditions, such as TSX approval. The contract was signed on July 21, 2021 by all parties. Final closing is scheduled for Wednesday, July 28th, 2021.
About Nanalysis Scientific Corp. (TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1)
Nanalysis trades on the TSX Venture Exchange (TSXV) in Canada with ticker symbol 'NSCI' ,Over the Counter (OTC) in the United States under the ticker symbol 'NSCIF', and on the Frankfurt Exchange (FRA) under the symbol '1N1'.
Nanalysis is an international business focused on capitalizing its proprietary technologies in magnetic resonance (MR) that go into NMR spectrometers and magnetic resonance imaging (MRI). Nanalysis operates out of two subsidiaries, Nanalysis Corp. and RS2D S.A.S. (RS2D).
Nanalysis Corp. is an industry leader in developing and manufacturing compact MR spectrometers for laboratory and industrial markets. Its advanced 60 and 100 MHz spectrometers require no liquid helium or other cryogens. These devices are used by chemical professionals spanning a wide variety of industries, including oil and gas, chemical, mining, pharmaceutical, and biotechnology.
Through its European subsidiary RS2D, the Company's electronic boards and software are used in conventional NMR and MRI equipment and are being incorporated into next-gen MRI systems as well as miniaturized MRI devices.
<<<
>>> Nanalysis Engages Firms to Drive Investor Communication Programs
Yahoo Finance
July 6, 2021
https://finance.yahoo.com/news/investor-relations-initiative-011900232.html
CALGARY, AB, July 6, 2021 /CNW/ - Nanalysis Scientific Corp. ("the Company", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), a leader in portable MRI and NMR machines for healthcare and industrial applications would like to announce that it has engaged North Equities, Peterson Capital and Stonegate Capital Partners to raise awareness of the Company's exciting story with a broader audience across North America.
Mr. Krakiwsky said "This is the first major investor communication program we have undertaken as a Company and we are committed to bringing our unique growth story to a bigger audience. With our strong fundamentals, including production of our new 100MHz product, the Company is scaling up to meet strong demand. We feel the time is right to attract new investors and shine a spotlight on our unique market position."
North Equities
North Equities is a firm specializing in algorithmic digital marketing with a specialization in social media campaigns. North Equities will serve as a marketing consultant to help establish an audience on social media and raise awareness on digital platforms. They have a strong track record of effectively sharing company stories in the digital realm and we expect them to help the Company attract a younger, more tech savvy investor looking for a growth story in disruptive technologies.
Peterson Capital
Peterson Capital provides capital markets advisory and corporate communications to Canada's leading growth companies. Peterson Capital specialize in helping CEOs & CFOs earn more capital markets support for their company, raising their profile and helping provide easier access to financing sources. This is achieved by introducing their clients to our network of leading Investment Advisors, fund managers, and family office managers in Canada and in Europe.
Stonegate Capital Partners
Stonegate Capital Partners will provide investor relations services to the Company with a specific focus on the US small-cap institutional investment community. Stonegate Inc. is a 40-year-old investor relations, and research firm based in Dallas, Texas. Its research covers companies in a variety of industries and is distributed to its wide network of institutional high net worth investors. Stonegate's primary focus is assisting small cap companies to achieve their capital markets objectives and to both increase and strengthen their institutional shareholder base across the United States.
Stonegate will receive US$5,000 per month for three months commencing July 6, 2021 and US$3,000 per month for three additional month. The term of the agreement is six months and may be cancelled subsequently, in writing, with standard notice provisions. The agreement is subject to the acceptance of the TSX Venture Exchange.
About Nanalysis Scientific Corp. (TSXV: NSCI, OTCQX: NSCIF, FRA:1N1)
Nanalysis trades on the TSX Venture Exchange (TSXV) in Canada with ticker symbol 'NSCI' ,Over the Counter (OTC) in the United States under the ticker symbol 'NSCIF', and on the Frankfurt Exchange (FRA) under the symbol '1N1'.
Nanalysis is an international business focused on capitalizing its proprietary technologies in nuclear magnetic resonance (NMR) that go into NMR spectrometers and magnetic resonance imaging (MRI). Nanalysis operates out of two subsidiaries, Nanalysis Corp. and RS2D S.A.S. (RS2D).
Nanalysis Corp. is an industry leader in developing and manufacturing compact NMR spectrometers for laboratory and industrial markets. Its advanced 60 and 100 MHz spectrometers require no liquid helium or other cryogens. These devices are used by chemical professionals spanning a wide variety of industries, including oil and gas, chemical, mining, pharmaceutical, and biotechnology.
Through its European subsidiary RS2D, the Company's electronic boards and software are used in conventional NMR and MRI equipment and are being incorporated into next-gen MRI systems as well as miniaturized MRI devices.
<<<
>>> Nanalysis Announces Q2 2021 Revenue up 120% over Q2 2020
Yahoo Finance
Tue, July 13, 2021
https://finance.yahoo.com/news/nanalysis-announces-q2-2021-revenue-203000835.html
CALGARY, AB, July 13, 2021 /CNW/ - Nanalysis Scientific Corp. ("the Company", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), a leader in portable MRI and NMR machines for healthcare and industrial applications, announced quarterly preliminary revenue of $4.4 million in Q2 of 2021, a 120% increase over Q2 2020.
While the company is not reporting full financials until the middle of August, CFO, Luke Caplette states: "We wanted to release our top line numbers to highlight our exciting growth and strengthening company fundamentals. We are continuing to see strong results from our efforts in 2020. The team did a remarkable job on all levels to achieve this level of growth. We demonstrated positive EBITDA in Q1 2021, and our cost structure has remained relatively unchanged. As a result, we expect solid profitability on an EBITDA basis when we release our full Q2 financials".
CEO, Sean Krakiwsky states "We showed over 115% revenue growth in Q1, and again now with 120% growth in Q2 as compared to the same quarter in the prior year. These results show that we remain on this growth trajectory."
"The benefits of our first acquisition are clearly showing on the top line and also as a technology tuck-in with the integration of the new electronics platform into our 100 MHz product. Fueled by increasing production of our 100 MHz product, continued growth in 60 MHz sales, as well as sales related to our MRI and NMR electronics modules, we are very optimistic about 2021 and beyond."
Mr. Krakiwsky continued: "We will continue to combine strong organic growth with new, complementary acquisitions in magnetic resonance that are accretive and of medium and long-term strategic importance."
The financial disclosure in this release is unaudited and could be subject to revision when the company releases its financial statements for the quarter.
About Nanalysis Scientific Corp. (TSXV: NSCI, OTCQX: NSCIF, FRA:1N1)
Nanalysis is listed on the TSX Venture Exchange (TSXV) in Canada with ticker symbol 'NSCI',Over the Counter (OTC) in the United States under the ticker symbol 'NSCIF', and on the Frankfurt Exchange (FRA) under the symbol '1N1'.
Nanalysis is an international business focused on capitalizing its proprietary technologies in nuclear magnetic resonance (NMR) that go into NMR spectrometers and magnetic resonance imaging (MRI). Nanalysis operates out of two subsidiaries, Nanalysis Corp. and RS2D S.A.S. (RS2D).
Nanalysis Corp. is an industry leader in developing and manufacturing compact NMR spectrometers for laboratory and industrial markets. Its advanced 60 and 100 MHz spectrometers require no liquid helium or other cryogens. These devices are used by chemical professionals spanning a wide variety of industries, including oil and gas, chemical, mining, pharmaceutical, and biotechnology.
Through its European subsidiary RS2D, the Company's electronic boards and software are used in conventional NMR and MRI equipment and are being incorporated into next-gen MRI systems as well as miniaturized MRI devices.
<<<
POET’s Interposer Platform is the Most Versatile, Lowest
Cost and Most Scalable Integration Platform
https://poet-technologies.com/docs/presentations/POET-Needham-Virtual-Tech-Conference-May-2021.pdf
LWLG -
https://static1.squarespace.com/static/5f8f6ccd480c9f1fd7a7e11e/t/60ce09ebea2dce2a102e1624/1624115691773/Wide+Moat+-+LWLG.pdf
>>> June 18, 2021
Best Idea: LWLG
Wide Moat Partners recommends the common stock of Lightwave Logic, Inc. (OTCQX: LWLG).
Wide Moat Partners are focused, long-term investors in businesses with entrepreneurial management and
sustainable competitive advantages. We believe the common stock of LWLG is materially undervalued
and should be worth ~10x from current levels and potentially ~100x in its long-run valuation.
Briefly, with total freedom of manufacturing, LWLG’s patented polymers will drive the future of
computing. Their technology is designed to transmit data at dramatically higher speeds with far less
power consumption.
The following video from May 27, 2021, is a primer on the business. Feel free to skip through the COVID
update, which fortunately did not have much to note.
The opportunity exists today because there is extreme demand for increased network capacity at lower
power. LWLG will reduce network energy costs and enable faster data transmission. Further, they have
never had meaningful revenue, and to date LWLG has not signed any partnership deals, therefore their
future is not written in stone. This is why we believe the valuation of LWLG is only ~$700M. However, it
does not take much imagination to read between the lines of management’s writings and video updates
and deduce that LWLG is on the precipice of mass commercialization and extraordinary value creation
for long-term shareholders.
On page 5 of this linked investor presentation, LWLG management uses widely held market expectations
to show the Tangible Addressable Market is growing very quickly and by 2025 should be approximately
$44B. In February of 2020 at the Noble Securities Conference, Jim Marcelli declared that LWLG could
have one third of this market. Since Marcelli’s prognostication, LWLG has not publicly said what
percentage of the market it believes it could capture because we believe the projections are large
enough that people would think they are being dishonest.
Management and the board of directors of LWLG are another reason we are invested as we believe they
are of superb quality. CEO, Michael Lebby co-founded Intel’s photonics division in 2000, invested at Intel
Capital (Intel’s internal VC company), cut his teeth on the first iterations of photonics at Bell Labs, and
leads photonics industry associations which set roadmaps for the future of the industry. The impressive
board of directors includes the well-regarded former CTOs of Corning and JDS Uniphase (now
Lumentum), Dr. Joseph Miller and Dr. Frederick Leonberger, respectively. These people are engineering
PhD’s and are known throughout their careers to be straight shooters and successful businessmen.
Further, management and the board are paid in shares/options of LWLG stock, which signals their strong
belief and support of the company and aligns their interests with ours.
We believe capturing one third of the market is a bit overzealous, so for the rest of this writing let us
hyper-conservatively use 3%, which would be $1.3B of revenue. This is only one of their potential
revenue lines, therefore actual numbers are likely higher.
LWLG has made it clear they will not use a tremendous amount of capex to build their own foundries
and instead will most likely partner with multiple large foundries using either licensing deals or
technology transfers to remain capital light. Basically, LWLG will use Apple’s model of partnering with
others (for Apple, partners like Foxconn and TSMC) to spin its material onto devices.
There is a myriad of short- and long-term catalysts and Lebby telegraphs their moves in the videos and
presentations above. Nearest term is an uplist to Nasdaq which will bring other institutional buyers and
more stable price discovery. We believe the actual float of shares available for sale is much lower than
~105M as at least 60-65% of shareholders we know to be similarly long-term minded and are not selling
their shares until the story plays out.
The main catalysts: As evaluation is underway with Tier-1 partners under NDA today, we believe LWLG
will at some point in the near future (~6-18 months) sign multiple partnerships with foundries and end
users to integrate LWLG material using current semiconductor architecture. This will be in the form of a
co-authored press release. Once the first partnership is struck, we believe the other major
semiconductor companies will have to find an alternative way to increase speed and lower power
consumption; otherwise, competitively will be forced to partner with LWLG. This in our opinion could
lead to large-scale adoption of the LWLG material perpetuating the value creation flywheel for
shareholders.
The key risk to the business is another technology leapfrogging them and LWLG’s patents being sold as
an expensive science experiment. Yet, as Lebby points out 15 minutes into the video linked above, the
competition today cannot compete in the combination of speed, size, power, and stability – the four
pillars of semiconductor success. For that reason, we believe we are buying a business in an industry
with extraordinary barriers to entry at a price near its liquidation value.
Due to their capital light business model, we believe LWLG will keep expenses relatively low and profit
margins quite high for a long period of time. The unique nature of their material and dynamics of the
semiconductor market will create what Warren Buffett (we recognize this is out of his strike zone, but it
is not out of ours) likes to call a wide moat around their business for the foreseeable future, allowing the
company to earn very high rates of return on its invested capital.
The math of this business is incredibly simple due to a pristine balance sheet and capital structure. They
have no debt and one class of common stock.
Assuming a 40% profit margin (which we believe to be conservative), earnings on $1.3B of revenue
would be $500M in 2025. Employing a conservative earnings multiple, we can think about the valuation
of this business – using a 20 P/E on that level of earnings yields a $10B market valuation. Since there are
approximately 105M shares outstanding, this leads to a price of about $95, more than 10x where the
business trades today. All of these numbers are very rough estimates, nonetheless, if LWLG captures any
of the market, our patience will be rewarded.
We look forward to a world Powered by Lightwave Logic.
/s/ WIDE MOAT
<<<
>>> Nanalysis Scientific Corp. (NSCIF), develops, manufactures, and sells compact nuclear magnetic resonance (NMR) spectrometers and MR imaging equipment for the pharmaceutical, biotech, chemical, security, food, materials, and education industries. It operates through Nanalysis, RS2D, and Corporate segments. The company also manufactures and sells cutting-edge electronics components for precision analytical instruments; and provides monitoring and supporting services for its NMR technologies. It sells its instruments in approximately 40 countries. The company is headquartered in Calgary, Canada. <<<
>>> Nanalysis Scientific Corp. Reports First Quarter 2021 Financial Results
Yahoo Finance
May 20, 2021
https://finance.yahoo.com/news/nanalysis-scientific-corp-reports-first-083600889.html
CALGARY, AB, May 20, 2021 /CNW/ - Nanalysis Scientific Corp. ("the Company", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), released today its first quarter 2021 results.
OVERALL PERFORMANCE
For the three months ended March 31, 2021, the Company reported consolidated revenue of $3,277K, an increase of $1,754K or 115% from the comparative period in 2020. The increase in revenue is due to the completion of ongoing RS2D contract milestones and shipments of Nanalysis' new flagship 100 MHz spectrometer. During the quarter Nanalysis recognized revenue related to six 100MHz units. The gradual ramp up of manufacturing limited production quantities in the first quarter, leaving Nanalysis with 22 100MHz orders in the growing order backlog.
As of March 31, 2021 the Company has $3,924K of unearned revenue (December 31, 2021 $2,868K), of which $1,144K relates to prepayments for the 100MHz. The increase was due to customer deposits on pre-orders for RS2D products, partially offset by shipments of the 100MHz against prepaid orders.
Gross profit for the three months ended March 31, 2021 was $2,122K (a margin of 65%) compared to gross profit of $982K (a margin of 64%) for Q1 2020.
The Company recorded earnings before other items of $267K, as compared to a loss before other items of $464K in Q1 2020. The Company's comprehensive loss for the three months ended was $418K (March 31, 2020 - $935K), an improvement of $517K or 55% from the comparative period in 2020. The improvement is attributed to a significant increase in revenue, and increased finance income that has been partially offset by increased depreciation and amortization, increased stock-based compensation expense, increased research and development expenses, and RS2D earn-out payment.
FINANCIAL POSITION
At March 31, 2021, the Company had $4,662K of working capital (December 31, 2020 - $3,049K), including $4,660K in cash (December 31, 2020 - $3,158K). The Company has an undrawn line of credit of $2,000K from its commercial bank and $167K of available borrowing on the Western Economic Diversification Canada interest free loan.
OUTLOOK
Sean Krakiwksy, CEO of the Company states "I am pleased to report solid first quarter 2021 financial results despite the negative impacts the global pandemic has had on our operations. Our efforts in 2020 are starting to manifest themselves in our results. The initial shipments of our 100MHz product, ongoing demand for our 60MHz, and continued interest in the RS2D product lines have contributed to our strong quarter. Manufacturing processes continue to be streamlined and standardized. This will increase the number of 100MHz units that were able to ship going forward, and we expect to reduce the order fulfillment lag time and clear our current order backlog."
The Company has completed the first quarter with an increase of $1.5 million to working capital, a strong sales pipeline and continued demand for the new 100MHz product. The Company has successfully adapted to pandemic operations and believes that the eventual lifting of covid restrictions will only further boost growth. The Company is well-positioned to execute current initiatives and continues to drive new expansion opportunities. As always, we will do so while striving to deliver value to our shareholders.
About Nanalysis Scientific Corp. (TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1)
Nanalysis trades on the TSX Venture Exchange (TSXV) in Canada with ticker symbol 'NSCI', Over-the-Counter (OTC) in the United States under the ticker symbol 'NSCIF', and on the Frankfurt Exchange (FRA) under the symbol '1N1'.
Nanalysis is an international business focused on capitalizing its proprietary technologies in nuclear magnetic resonance (NMR) that go into NMR spectrometers and magnetic resonance imaging (MRI). Nanalysis operates out of two subsidiaries, Nanalysis Corp. and RS2D S.A.S. (RS2D).
Nanalysis Corp. is an industry leader in developing and manufacturing compact NMR spectrometers for laboratory and industrial markets. Its cutting edge 60 and 100 MHz spectrometers require no liquid helium or other cryogens. Its spectrometers are used by chemical professionals spanning industries, including, but not limited to, oil and gas, chemical mining, pharmaceutical, and biotechnology.
Through its European subsidiary RS2D, the Company's electronic boards and software are used in MRI equipment and are being incorporated into next-gen MRI systems as well as miniaturized MRI devices.
<<<
>>> Energous Corporation (WATT) develops wire-free charging solutions. The company develops WattUp wireless power technology that consists of semiconductor chipsets, software controls, hardware designs, and antennas that enables radio frequency based wire-free charging for electronic devices. It has a strategic partnership with Xentris Wireless to develop ruggedized products for military applications using the company's radio frequency based charging technology. The company's products are used in home, medical, automotive, industrial, military and office. Energous Corporation was formerly known as DvineWave Inc. and changed its name to Energous Corporation in January 2014. The company was founded in 2012 and is headquartered in San Jose, California.
<<<
>>> Else Nutrition Reports First Quarter 2021 Results, Delivers 90% Quarter over Quarter Revenue Growth
Yahoo Finance
May 31, 2021
https://finance.yahoo.com/news/else-nutrition-reports-first-quarter-025900215.html
VANCOUVER, BC, May 31, 2021 /PRNewswire/ - ELSE NUTRITION HOLDINGS INC. (TSXV: BABY) (OTCQX: BABYF) (0YL.F) ("Else" or the "Company") the Plant-Based baby, toddler and children nutrition company, today announced results for its first quarter ended March 31, 2021. Management is pleased to announce it achieved significant progress executing its go-to-market plan in the US market to become one of the leading providers of baby food products as a healthy alternative to dairy-based formulas. The following summarizes major execution points achieved in the first quarter of 2021, as well as execution on our business strategy. Full financial results can be found in the Company News section of our website at https://elsenutrition.com/pages/investor-relations or on SEDAR at www.sedar.com
Q1 2021 Financial Highlights
Q1 2021 revenues of C$1,135 thousand, an 90% growth over revenues of C$598 thousand in Q4 2020 and an increase of 282% vs. revenues over C$297 thousand in Q1 2020.
149% growth in quarter-over-quarter Formula revenues of C$862 thousand in Q1 2021 over C$346 thousand in Q4 2020.
First quarter to recognize formula revenues from the retail market. The Company successfully launched retail sales at Sprouts Farmers Market, a leading natural food retailer in the US.
Successfully completed the first commercial production of ELSE's second product – Complete Nutrition for Kids (3+ years; in powder form). The product is expected to launch online in Vanilla and Chocolate flavors in Q2 2021.
Successfully increased Amazon.com formula number of orders by 66% and average basket value by 15% quarter-over-quarter. In March 2021 Else launched a new product store in amazon.com to improve its position on this critical platform.
Successfully onboarded UNFI (the largest US natural food distributor), KeHE Distributors and Imperial Distributors, together providing reach to most retail stores in the U.S.
Selected to the high-profile KeHE Distributor's Elevate program.
Successfully listed at Raley's, a 126 door West Coast retailer that plans to launch in Q2 2021.
Successfully launched on three online platforms – Thrive Market, a leading natural food e-tailer with 500,000 subscribers; iHerb, a US based international online platform that serves 180 countries; and PlantX, a new plant-based e-tailer.
Operating loss was C$3,945 thousand, compared to C$1,532 thousand in the first quarter of 2020. Net profit in Q1 2021 was C$2,182 thousand, or C$0.02 per share, compared to net loss of C$1,651 thousand, or C$0.02 per share in Q1 2020. The net profit and loss include the non-cash revaluation of Investor warrants liability of C$6,565 thousand Profit in Q1 2021 and C$336 thousand loss in Q1 2020.
Cash flow used for operating activities was C$4,338 thousand, compared to C$1,220 thousand in the first quarter of 2020.
Cash position was C$22,085 thousand as of March 31, 2021 (including restricted cash and short-term bank deposit).
The Company had no Loans liability as of March 31, 2021.
Hamutal Yitzhak, Else CEO, commented: "I am very proud of our achievements this quarter. We continued delivering rapid growth in our business while we successfully launched our first retail stores and started working with the largest US natural food distributors".
Impact of COVID-19
We experience the effect of the pandemic in all areas of our business, from delays in raw material deliveries, to clinical and product development projects and absence of key persons in the company from time to time. Due to lockdowns and other COVID-19 related measures all our business meeting, marketing events, conferences and expos were either canceled or turned virtual, slowing down the pace of our business development efforts.
About Else Nutrition Holdings Inc.
Else Nutrition GH Ltd. is an Israel-based food and nutrition company focused on developing innovative, clean and plant-based food and nutrition products for infants, toddlers, children, and adults. Its revolutionary, plant-based, non-soy, formula is a clean-ingredient alternative to dairy-based formula. Else Nutrition (formerly INDI) won the "2017 Best Health and Diet Solutions" award at the Global Food Innovation Summit in Milan. Else Plant-Based Complete Nutrition for Toddlers was recently ranked as the #1 Top seller in the baby and toddler formula category on Amazon. The holding company, Else Nutrition Holdings Inc., is a publicly traded company, listed as TSX Venture Exchange under the trading symbol BABY and is quoted on the US OTC Markets QX board under the trading symbol BABYF and on the Frankfurt Exchange under the symbol 0YL. Else's Executives includes leaders hailing from leading infant nutrition companies. Many of Else advisory board members had past executive roles in companies such as Mead Johnson, Abbott Nutrition, Plum Organics and leading infant nutrition Societies, and some of them currently serve in different roles in leading medical centers and academic institutes such as Boston Children's Hospital, Pediatrics at Harvard Medical School, USA, Tel Aviv University, Schneider Children's Medical Center of Israel, Rambam Medical Center and Technion, Israel and University Hospital Brussels, Belgium.
<<<
>>> Burcon JV Company, Merit Functional Foods, Achieves First Commercial Production of Canola Protein
Yahoo Finance
April 12, 2021
https://finance.yahoo.com/news/burcon-jv-company-merit-functional-120000078.html
A Global Plant-based Protein First For Canola
Vancouver, British Columbia--(Newsfile Corp. - April 12, 2021) - Burcon NutraScience Corporation (TSX: BU) (OTCQB: BUROF), a global technology leader in the development of clean-label, plant-based proteins for foods and beverages, is pleased to announce that its joint venture company, Merit Functional Foods Corporation ("Merit Foods" or "Merit"), has achieved first commercial production of its novel lineup of Puratein® canola proteins. Merit's new, state-of-the-art, plant-based protein production complex is now the first and only commercial-scale facility in the world capable of producing food-grade protein from canola, the world's second-largest oilseed crop. Merit intends to continue optimizing the manufacturing process in the coming weeks, with an expectation of fulfilling commercial commitments in Q2 for its better-tasting, better-functioning and better-for-you plant proteins.
"This is a truly momentous achievement for us and one that has been a long time in the making," said Johann F. Tergesen, Burcon's president and chief executive officer, adding: "Burcon first embraced the vision of canola's potential as a premium, food-grade protein source over 20 years ago. Today, Merit Foods, with its just-completed high-tech plant protein production facility, is bringing eco-friendly canola proteins to market using Burcon's patented processing technology. These proteins stand to change the way the world's consumers get their protein."
"This milestone is a significant step toward fulfilling canola's enormous global potential as an important, new, environmentally friendly source of high-quality, plant-based protein for food and beverage product development. As the world's second-largest oilseed crop, canola protein is perfectly positioned to offer a sustainable way to feed and nourish the world's growing population."
Canola was originally developed out of rapeseed in the 1970s after many years' efforts by Canadian researchers Baldur Stefansson and Keith Downey, considered the fathers of canola. This scientific advance enabled the production and use of canola oil for human consumption. Since that time, canola agricultural production has expanded globally to now be the number two oilseed in the world-behind soybeans and ahead of sunflower seed, peanuts and cottonseed. Burcon's world-leading team of food scientists and chemical engineers has worked for more than two decades to unlock the full nutritional and functional properties of canola proteins. Burcon's efforts have culminated in the opening of Merit's new plant protein processing facility, and now the commercial-scale production of Merit's novel lineup of Puratein® canola proteins.
Merit's new, ultramodern, plant-based protein production facility is dedicated to the production, of novel pea and canola protein ingredients using licensed technology from Burcon. Unique in its design and structured for rapid expansion, Merit's 94,000-square-foot facility has been engineered and constructed to be able to process both non-GMO canola and yellow field peas, giving it the ability to produce Merit's lineup of Puratein® canola proteins, its Peazazz®and Peazac® pea proteins, and its MeritPro™ protein blends. Merit's Puratein®, Peazazz®, Peazac® and MeritPro™ are ideal ways for food and beverage companies to give their products a much-needed nutritional boost while remaining dairy-free, soy-free, grain-free and gluten-free.
Broadcast-quality Burcon and canola video footage can be downloaded here.
About Burcon NutraScience Corporation
Burcon is a global technology leader in the development of clean-label, plant-based proteins for foods and beverages. With over 300 issued patents and more than 225 additional patent applications developed over a span of more than 20 years, Burcon has grown an extensive portfolio of composition, application and process patents covering novel plant-based proteins derived from pea, canola, soy, hemp, sunflower seed and more. In 2019, Merit Functional Foods Corporation was established in a joint venture between Burcon and three veteran food industry executives. Merit Foods has built a state-of-the-art protein production facility in Manitoba, Canada to produce, under licence, Burcon's novel pea and canola protein ingredients. For more information, visit www.burcon.ca.
<<<
>>> Burcon NutraScience Corporation (BRCN), together with its subsidiary, develops plant proteins and ingredients for use in the food and beverage industries in Canada. The company's products include CLARISOY, a soy protein for use in sports nutrition beverages, dairy alternative yogurts and cheeses, powdered beverage mixes, coffee creamers, and other foods and nutritional products; and Peazazz, a pea protein for dairy alternative products, such as protein bars and crisps, weight management and meal replacement products, and vegetarian and vegan foods, as well as dry blended and ready-to-drink beverages. It also provides Supertein, a canola protein isolate for use in beverages, confectionery, aerated desserts, and protein bars; and Puratein, a canola protein isolate for use in baked goods, protein cereal bars, dressings, sauces, and meat substitutes. The company was formerly known as Burcon Capital Corp. and changed its name to Burcon NutraScience Corporation in October 1999. Burcon NutraScience Corporation was founded in 1998 and is headquartered in Vancouver, Canada. <<<
>>> Burcon is a global technology leader in the development of clean-label, plant-based proteins for foods and beverages. With over 300 issued patents and 200 additional patent applications developed over a span of more than 20 years, Burcon has grown an extensive portfolio of composition, application and process patents covering novel plant-based proteins derived from pea, canola, soy, hemp, sunflower seed and more. In 2019, Merit Functional Foods Corporation ("Merit Foods") was established in a joint venture between Burcon and three veteran food industry executives. Merit Foods has built a state-of-the-art protein production facility in Manitoba, Canada to produce, under licence, Burcon's novel pea and canola protein ingredients. For more information, visit www.burcon.ca.
https://marketwirenews.com/news-releases/burcon-to-begin-trading-on-nasdaq-8030639522980966.html
<<<
>>> Byrna Technologies to Commence Trading on Nasdaq
Yahoo Finance
May 4, 2021
https://finance.yahoo.com/news/byrna-technologies-commence-trading-nasdaq-120000605.html
ANDOVER, Mass., May 4, 2021 /PRNewswire/ -- Byrna Technologies Inc. (OTCQB: BYRN) (CSE: BYRN) ("Byrna" or "the Company") today announced that The Nasdaq Stock Market LLC has approved the listing of the Company's common stock on the Nasdaq Capital Market ("Nasdaq"). The Company expects to begin trading on the Nasdaq on Wednesday May 5, 2021 under the symbol "BYRN." The Company's common stock will continue to trade on the OTCQB until market close on May 4, 2021, and will continue to trade on the Canadian Stock Exchange.
"The Nasdaq listing is an important milestone for Byrna and is a testament to Byrna's growth and evolution as a publicly traded company over the last several years," said Bryan Ganz, CEO of Byrna. "We are enthusiastic about this listing because we believe it will help elevate the Company's public profile, expand our shareholder base, improve liquidity and enhance shareholder value."
Mr. Ganz continued, "Our flagship product, the Byrna®HD has proven to be a game changer in the market for non-lethal personal security devices, and we expect the product innovations we have been developing to further solidify our position as a leader in this market. The Byrna HD is a product for the times, driven by the growing need for both civilians and law enforcement professionals to have a safe and effective alternative to lethal firearms to protect themselves, their families, and their communities. Our rapid sales growth over the past year reflects this need and our broad and expanding brand appeal with consumers. We believe we are well positioned for continued growth and that we have the human and financial resources in place necessary to support that growth."
About Byrna Technologies Inc.
Byrna is a technology company, specializing in the development, manufacture, and sale of innovative, non-lethal personal security solutions. For more information on the Company, please visit the corporate website here or the Company's investor relations site here. The Company is the manufacturer of the Byrna® HD personal security device, a state of the art handheld CO2 powered launcher designed to provide a non-lethal alternative to a firearm for the consumer, private security, and law enforcement markets. To purchase Byrna products visit the Company's e-commerce store.
<<<
>>> SenesTech Announces Successful Completion of a Long Term Agricultural Deployment of ContraPest®
Yahoo Finance
March 18, 2021
https://finance.yahoo.com/news/senestech-announces-successful-completion-long-201500275.html
PHOENIX, March 18, 2021 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), a developer of proprietary, next generation technologies for managing animal pest populations through fertility control, today announced the conclusion of agricultural deployments of ContraPest® with demonstrated, sustained success in reducing rat populations and improving operating economies in poultry settings.
SenesTech, Inc. has developed an innovative technology for managing animal pest populations through fertility control as opposed to a lethal approach. The Company's first fertility control product, ContraPest(R), is marketed for use initially in controlling rat infestations.
Rats in poultry facilities cause significant damage and can be hazardous to the health of flocks due to disease transmission, equipment impairment, pullet predation, loss of grain, and, in severe cases, may interrupt production. ContraPest was added to the existing integrated pest management plans at two poultry farming operations. At an egg production farm on the west coast, the rat populations were surveyed monthly using cameras for over a year to measure a reduction in rat activity throughout ContraPest treatment. On a second farm, a pullet house on the east coast, staff tracked consumption rates and economic impacts caused by rats before and after the introduction of ContraPest.
Results from both farms showed a substantial reduction in rats within six months of deployment and continued success as treatment progressed.
The west coast egg farm had a confirmed 90% decline in rat activity within 12 months of adding ContraPest.
The east coast pullet farm reported an 88% improvement in pullet survival after reducing their rat population with ContraPest. The savings projected by the customer of adding ContraPest to the their pest management plan were over $400,000 in increased revenue and decreased costs.
Overall, rodent control programs on both farms were significantly enhanced by the reduction in rat activity provided by ContraPest and the clear economic value generated.
Ken Siegel, CEO of SenesTech, commented, "While these results were from deployments at poultry facilities, the results are immediately applicable to many other agricultural situations. Anywhere there is high quality grain, there is the potential for rat infestations, and ContraPest is now proven in the field to reduce those infestations, reduce the negative economic impact, and improve overall food security."
About SenesTech
SenesTech is changing the model for pest management by targeting one of the root causes of the problem: reproduction.
ContraPest® is an innovative technology with an approach that targets the reproductive capabilities of both sexes in rat populations, inducing egg loss in female rats and impairing sperm development in males. Using a proprietary bait delivery method, ContraPest® is dispensed in a highly palatable liquid formulation that promotes sustained consumption by rat communities. ContraPest® is designed, formulated and dispensed to be low hazard for handlers and non-target species such as wildlife, livestock and pets, where the active ingredients break down rapidly.
We believe ContraPest® will establish a new paradigm in rodent control, resulting in a decreased reliance on lethal options. For more information visit the SenesTech website at www.senestech.com.
<<<
>>> Investopedia - What is the OTCQB ?
Investopedia
By JAMES CHEN
Feb 2, 2021
https://www.investopedia.com/terms/o/otcqb.asp
What Is the OTCQB?
The OTCQB, also called "The Venture Market," is the middle tier of the over-the-counter (OTC) market for U.S. stocks. It was created in 2010 and consists mainly of early-stage and developing U.S. and international companies that are not yet able to qualify for the OTCQX but are not as speculative as the lowest-tier Pink Sheets.
The OTCQB replaced the Financial Industry Regulatory Authority (FINRA)-operated OTC Bulletin Board (OTCBB) as the main market for trading OTC securities that report to a U.S. regulator. As it has no minimum financial standards, the OTCQB often includes shell companies, penny stocks, and small foreign issuers.
KEY TAKEAWAYS
The OTCQB is the mid-tier OTC equity market, which lists primarily early-stage and developing companies in the U.S. and international markets, largely replacing the OTCBB system.
OTCQB companies must meet certain minimum reporting standards, pass a bid test, and undergo annual verification.
The other OTC tiers are the highest quality OTCQX, and the most speculative Pink Sheets
Basics of the OTCQB
The over-the-counter or OTC market is a decentralized market where securities not listed on major exchanges are traded directly by a network of dealers. Instead of providing an order matchmaking service like the NYSE, these dealers carry inventories of securities in order to facilitate any buy and sell orders.
The OTCQB marketplace is run through OTC Link, an inter-dealer quotation and trading system developed by OTC Markets Group. OTC Link is registered with the SEC as a broker-dealer and also as an alternative trading system (ATS). OTC Link enables broker-dealers to not only post and disseminate their quotes, but also negotiate trades through the system’s electronic messaging capability. This feature enabled it to effectively replace FINRA’s OTCBB, which was a quotation-only system.
All broker-dealers that trade OTCQB, OTCQX, and OTC Pink securities have to be FINRA members and registered with the SEC; they are also subject to state securities regulations. As with exchange-traded securities, investors trading OTC securities are protected from an unethical broker-dealer’s illegal practices by the same SEC/FINRA rules such as Best Execution, Limit Order Protection, Firm Quotes, and Short Position Disclosure.
Rules of the OTCQB
To be eligible, companies must be current in their reporting, undergo annual verification and certification, meet a $0.01 bid test, and may not be in bankruptcy. Companies listed here report to a U.S. regulator such as the SEC or FDIC. The fees for listing on OTCQB markets is $12,000 per annum, with a one-time application fee of $2,500.
Companies trading on the OTCQB must follow standards to improve transparency and exclude companies that are most likely to be associated with stock promoters and other shady operators. And while stocks trading in the OTCQB have many of the same protections as more established, larger stocks, they are still considered to be more speculative penny stocks.
There is also no guarantee that stocks trading in the OTC market are of higher quality than penny stocks trading on different OTC tiers or even different OTC marketplaces. As such, traders would be well served to implement strong due diligence before committing their capital.
<<<
>>> Winmark Corporation (WINA) operates as a franchisor of five retail store concepts that buy, sell, trade, and consign merchandise primarily in the United States and Canada. The company operates in two segments, Franchising and Leasing. Its franchises retail stores operate under the Plato's Closet, Once Upon A Child, Play It Again Sports, Style Encore, and Music Go Round brand names. The company's Plato's Closet brand stores buy and sell used clothing and accessories for the teenage and young adult market; and Once Upon A Child brand stores buy and sell used and new children's clothing, toys, furniture, equipment, and accessories primarily targeting parents of children ages infant to 12 years. Its Play It Again Sports brand stores buy, sell, trade, and consign used and new sporting goods, equipment, and accessories for various athletic activities, such as team sports, fitness, ski/snowboard, golf, and others; Style Encore brand stores buy and sell used women's apparel, shoes, and accessories; and Music Go Round brand stores buy, sell, trade, and consign used and new musical instruments, speakers, amplifiers, music-related electronics, and related accessories. In addition, the company is also involved in middle-market equipment leasing business focusing on technology and business-essential equipment for large and medium-sized businesses; and small-ticket financing business. As of March 28, 2020, it had 1,256 franchised stores. Winmark Corporation was founded in 1988 and is headquartered in Minneapolis, Minnesota.
<<<
>>> Byrna Technologies Inc. (BYRN), a less-lethal defense technology company, develops and manufactures less-lethal equipment and munitions. It offers Byrna line of handheld personal security devices, including the Byrna HD, a handheld personal security device which is designed to be used by civilians and private security professionals, as well as accessories and third-party products that are compatible with the Byrna HD, including the projectiles used in the Byrna HD; and less-lethal munitions that comprise impact rounds designed to stop an individual without causing permanent injury or death, as well as payload rounds carrying various chemical irritants and marking products designed for 40MM rifled launchers utilized by law enforcement, correctional services, and military markets. The company also sells 12 gauge less-lethal impact rounds. It serves military, correctional services, police agencies, private security, and consumers in the United States, Canada, and South Africa. The company was formerly known as Security Devices International, Inc. and changed its name to Byrna Technologies Inc. in March 2020. Byrna Technologies Inc. was founded in 2005 and is headquartered in Andover, Massachusetts. <<<
>>> EnWave Corporation Refining Development of a Medical Device to Relieve COVID-19 Symptoms
GlobeNewswire
August 25, 2020
https://finance.yahoo.com/news/enwave-corporation-refining-development-medical-130000090.html
VANCOUVER, British Columbia, Aug. 25, 2020 (GLOBE NEWSWIRE) -- EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the "Company"), announced today it is collaborating with the University of British Columbia (“UBC”) to investigate a manufacturing method for a new inhaler with the goal of using it to help provide relief for COVID-19 patients (the “Project”). The Project will be primarily funded by a $50,000 NSERC Alliance government research grant.
UBC researchers are searching for a drying method that would allow for the encapsulation of microparticles (used to improve the delivery and absorption of drugs) into an inhalable treatment. EnWave’s patented Radiant Energy Vacuum (“REV™”) dehydration technology has shown promise as a viable option for this specific manufacturing process.
UBC researchers involved are Assistant Professor Anubhav Pratap Singh and Professor David Kitts from UBC’s Faculty of Land and Food Systems, and Assistant Professor Mattia Bacca and Postdoctoral Fellow Alberto Baldelli from the Faculty of Applied Sciences.
“This inhalable treatment aims to provide relief to COVID patients while a vaccine is in development. We hope it can be more accessible, reasonably affordable and commercialized much sooner,” said Baldelli.
Currently, there are no preliminary results. However, the research team hopes to generate the first prototypes of encapsulated ACE2 (angiotensin-converting enzyme 2) by the end of the summer. At the same time, project collaborators from the University of Sydney and St. Paul’s Hospital in Vancouver are going to generate data on the toxicology of ACE2 to lung tissue.
Uniformity and process repeatability has previously been demonstrated through the use of REV™ technology in the pharmaceutical industry. A cGMP REV™ machine design has previously been built and has demonstrated fast drying cycles for vaccines (approx. 6 hours to 12 hours) with equal or superior retention of biological activity compared to traditional lyophilization techniques. Competing lyophilization technologies generally take 24 hours or longer to stabilize pharmaceutical products.
Researchers at UBC and EnWave are assessing the feasibility of REV™ technology for the manufacture of the inhalable ACE2 encapsulated microparticle. The Project will be segmented into two phases, a lab scale feasibility assessment and a proof of concept trial.
Recent funding for this research has been approved by the Government of Canada through the Natural Sciences and Engineering Research Council (“NSERC”). The Project is entitled: “Treating the early symptoms of Covid19 by encapsulating recombinant ACE2”.
“The innovative nature of our proprietary drying technology could support a breakthrough in the commercial feasibility of the COVID-19 treatment that our UBC collaborators have been developing,” stated EnWave’s CEO, Mr. Brent Charleton. “We hope that this Project will lead to a viable treatment against COVID-19 and help strengthen the fight against this pandemic.”
About EnWave
EnWave Corporation, a Vancouver-based advanced technology company, has developed Radiant Energy Vacuum (“REV™”) – an innovative, proprietary method for the precise dehydration of organic materials. EnWave has further developed patented methods for uniformly drying and decontaminating cannabis through the use of REV™ technology, shortening the time from harvest to marketable cannabis products.
REV™ technology’s commercial viability has been demonstrated and is growing rapidly across several market verticals in the food, and pharmaceutical sectors, including legal cannabis. EnWave’s strategy is to sign royalty-bearing commercial licenses with innovative, disruptive companies in multiple verticals for the use of REV™ technology. The company has signed over thirty royalty-bearing licenses to date. In addition to these licenses, EnWave established a Limited Liability Corporation, NutraDried Food Company, LLC, to manufacture, market and sell all-natural dairy snack products in the United States, including the Moon Cheese® brand.
EnWave has introduced REV™ as a disruptive dehydration platform in the food and cannabis sectors: faster and cheaper than freeze drying, with better end product quality than air drying or spray drying. EnWave currently offers two distinct commercial REV™ platforms:
nutraREV® which is a drum-based system that dehydrates organic materials quickly and at low-cost, while maintaining high levels of nutrition, taste, texture and colour; and,
quantaREV® which is a tray-based system used for continuous, high-volume low-temperature drying.
EnWave is also active in the pharmaceutical industry through a joint development agreement with GEA Lyophil, a leader in GMP drying machinery.
<<<
>>> ExxonMobil and Global Clean Energy Holdings (GCEH) Sign Agreement for Renewable Diesel
MarketWatch
Aug. 11, 2020
https://www.marketwatch.com/press-release/exxonmobil-and-global-clean-energy-holdings-sign-agreement-for-renewable-diesel-2020-08-11?siteid=bigcharts&dist=bigcharts&tesla=y
ExxonMobil has signed an agreement with Global Clean Energy Holdings to purchase 2.5 million barrels of renewable diesel per year for five years from a converted California refinery starting in 2022.
The renewable diesel will be sourced from a refinery acquired by Global Clean Energy in Bakersfield, California, which is being retooled to produce renewable diesel from Global Clean Energy’s patented varieties of camelina, a fallow land crop that does not displace food crops, and other non-petroleum feedstocks. Following scheduled production startup in 2022, ExxonMobil plans to distribute the renewable diesel within California and potentially to other domestic and international markets.
“Our agreement with Global Clean Energy builds on ExxonMobil’s longstanding efforts to develop and offer products that help meet society’s energy needs while reducing environmental impacts,” said Bryan Milton, president of ExxonMobil Fuels and Lubricants Company. “Chemically similar to petroleum-based diesel, renewable diesel can be readily blended for use in engines on the market today.”
“Our relationship with ExxonMobil is a perfect fit for Global Clean Energy and the Bakersfield biorefinery because it leverages ExxonMobil’s scale and unrivaled market perspective to unlock value for both companies,” said Richard Palmer, CEO of Global Clean Energy Holdings. “By combining upstream feedstock supply and downstream production, we are moving toward the fully integrated production model pioneered by ExxonMobil.”
In addition to camelina, various non-petroleum feedstocks, including used cooking oil, soybean oil, distillers’ corn oil and other renewable sources will be refined to produce the renewable diesel.
Based on analysis of California Air Resources Board (CARB) data, renewable diesel from various non-petroleum feedstocks can provide life-cycle greenhouse gas emissions reductions of approximately 40 percent to 80 percent compared to petroleum-based diesel.1
About ExxonMobil
ExxonMobil, one of the largest publicly traded international energy companies, uses technology and innovation to help meet the world’s growing energy needs. ExxonMobil holds an industry-leading inventory of resources, is one of the largest refiners and marketers of petroleum products, and its chemical company is one of the largest in the world. To learn more, visit exxonmobil.com and the Energy Factor.
<<<
>>> INTERVIEW: Fintech Company Coro to Launch Gold Payments App as it Prepares for Nasdaq Listing
IPO-Edge.com
July 21, 2020
By John Jannarone
https://finance.yahoo.com/news/interview-fintech-company-coro-launch-120008237.html
For most investors, the only sensible ways to own gold are to buy ETFs like SPDR Gold Shares (ticker: GLD) and iShares Gold Trust (ticker: IAU) or perhaps put coins and bars in a safe. But none of those options can help turn gold into a currency that’s convenient for payments.
Soon, gold payments will become much easier thanks to Coro Global Inc., which currently trades on the OTCQB (ticker: CGLO) and expects to soon begin trading on Nasdaq (ticker: CORO). Coro plans to launch an app on August 1 that will initially allow users to not only buy and sell gold, but make payments between each other as they might on PayPal Holdings Inc.’s Venmo – in dollars or gold.
In an interview with IPO Edge, Coro CEO J. Mark Goode explained that the company complies with regulators at three levels: The Securities and Exchange Commission (SEC), FinCEN at the U.S. Treasury, along with state banking and finance regulators. Coro also has a robust “know your customer” framework designed to reduce the risk of any bad actors joining the platform. And for even more peace of mind, customers can request that physical gold in their accounts be sent to them at any time.
Looking ahead, Mr. Goode sees opportunity in B2B payments and to enter international markets, starting with Mexico and Canada. The full interview is below:
IPO Edge: Who is the initial target user for the Coro app and is there a minimum amount of money needed to use it?
The initial Coro users will be U.S. individuals making payments between each other. Our users will have the ability to send and receive U.S. Dollars (USD), and for the first time, the same ability to send and receive gold (XAU). Coro has democratized access to gold for every user, regardless of income, wealth or financial experience.
After the U.S. roll-out to individual customers, Coro will focus on opening up access to business users and merchants for B2B/B2C transactions. Coro’s technology allows users to transact in U.S. dollars (USD) or gold (XAU) in increments as small as a penny. In 2021 Coro expects to expand to users in Mexico and Canada.
IPO Edge: Can Coro accommodate very large transactions in addition to small exchanges between friends as on Venmo?
Yes, our next generation AML/KYC compliance technology allows for careful due diligence and evaluation of all new Coro users during the onboarding processes. Our AML/KYC tech allows for the customer due diligence to be accomplished rapidly and efficiently, while ensuring a positive and convenient user experience. This enhanced due diligence during the onboard process, as well as sophisticated ongoing transaction monitoring technology, provides our users with the opportunity to transact in small amounts and at higher values.
IPO Edge: How quickly can someone be approved to begin using the app once it’s launched?
Users are able to download and enroll with Coro in a matter of minutes. Our customer verification and background check process is fully automated and contained within the mobile application. The customer enrollment experience is 3 minutes, or less.
IPO Edge: Have you taken steps to “know your customer” so to prevent bad actors from using Coro?
Yes, as mentioned above, we have built Coro on a strong foundation of compliance. Our AML / KYC solution for onboarding new users and monitoring their ongoing transactions for suspicious activity is cutting edge technology. Our AML/KYC technology monitors international compliance watchlists in real time and alerts Coro’s experienced compliance team so that they may take action.
IPO Edge: Have you had interest from potential users ahead of the app launch?
On a pre-launch basis, interest from prospective users has been very positive. During the past month approximately 3,500 interested Coro users have pre-registered on our website (visit: http://www.coro.global/). Commentary from the pre-registered users regarding the opportunity to own and send gold has been enthusiastic. The idea of reliable gold money is connecting with people. As mentioned previously, Coro will be launched on a commercial basis this summer.
IPO Edge: What kinds of regulatory requirements were necessary to launch?
Coro is regulated on three levels. First, as a public company we are regulated by the Securities Exchange Commission. Second, we are registered and regulated as a money services business by FinCEN at the U.S. Treasury. Third, Coro is regulated by state banking and finance regulators as a money transmission company. Regulation at both the Federal and State levels will enhance trust and confidence for Coro users.
IPO Edge: Can users request physical gold be sent to them from their accounts?
Yes, Coro users will have the opportunity to withdraw their gold for home delivery. The functionality for withdrawal and delivery will be implemented this year after our summer launch. All gold within the Coro user accounts belongs to our customers. The gold is fully allocated, insured and held by an independent vaulting custodian.
<<<
>>> Else Nutrition Provides Corporate Update
ACCESSWIRE
May 22, 2020
https://finance.yahoo.com/news/else-nutrition-provides-corporate-143000509.html
Engagement with Covet PR ahead of planned product launch in the U.S.; Covet specializes in alternative foods promotion with clients such as Beyond Meat, Banza, Kashi, Once Upon a Farm, and many others
Positive social campaign testing results, reached over 320,000 potential customers in the U.S.
Partnership with "Mom's Meet", a community of approximately 100,000 U.S. moms dedicated to exploring new children products
Product launch in the U.S. expected in late July or early August 2020 (4-8 week delay from original pre-July launch date due to Covid 19)
Toddler Nutrition product sampling campaign planned to launch on June 15, 2020
VANCOUVER, BC / ACCESSWIRE / May 22, 2020 / ELSE NUTRITION HOLDINGS INC. (BABY.V) (OTCQB:BABYF) ("Else" or the "Company"), a developer of plant-based alternatives to dairy-based baby nutrition, is pleased to provide the following corporate update.
Marketing for Upcoming Product Launch
Else is pleased to announce that it has engaged Covet PR, a national U.S.-based public relations firm devoted to food, beverage, beauty and lifestyle brands. Covet will) support the launch of Else products into the U.S. marketplace in Q3-2020. Covet's client roster includes impressive, disruptive and leading wellness brands, such as: Beyond Meat, Banza, Kashi, Once Upon a Farm, and many other better-for-you consumer product companies.
"As experts in the plant-based nutrition space, we are thrilled to be partnering with Else Nutrition for their U.S. launch," says Sara Brooks, Founder, and CEO of Covet PR. "At Covet PR, we are passionate about companies that are truly innovating, making this world a healthier and happier place. Furthermore, as a mom of two young children, I am equally as excited about having a better, complete nutrition solution I can depend on, and I look forward to sharing this brand with consumers nationwide."
During the month of April, Else executed its first paid test campaigns on social media platforms, showing highly promising results and customer engagement. The brand was exposed to over 320,000 potential U.S. customers, with more than double the industry average clickthrough rate. The clickthrough rate is a widely accepted industry standard indicator of high customer interest in the brand. Insights gleaned from this campaign will be integrated into a sampling campaign planned to launch on June 15th 2020, when customers will be able to order Else Toddler Nutrition samples.
The Company has also partnered with Mom's Meet, a dedicated community of approximately 100,000 U.S. moms exploring new consumer products for their children. The program will raise brand awareness among this group via digital communications, and will drive sampling for Else Plant-Based Toddler Nutrition.
Product Launch Date
Management is pleased to announce that the impact of the COVID-19 pandemic, on Company's business was minimal, causing an approximate 2 month delay in product launch which is currently scheduled for late July or early August 2020. Else also expects to finalize its agreement with a leading U.S.-based organic baby formula manufacturer for the production of its plant-based toddler nutrition product in June of 2020.
About Else Nutrition Holdings Inc.
Else Nutrition GH ltd. is an Israel-based food and nutrition company focused on developing innovative, clean and plant-based food and nutrition products for infants, toddlers, children, and adults. Its revolutionary, 100% plant-based, non-soy, formula is a clean-ingredient alternative to dairy-based formula. Else Nutrition won the "2017 Best Health and Diet Solutions' award at the Global Food Innovation Summit in Milan. The holding company, ELSE Nutrition Holdings Inc, is a publicly-traded company, listed as TSX-V: BABY, as part of the TSX Venture Exchange and as OTCQB: BABYF as part of the NY OTC QB Exchange. Else's Executive and Advisory Board includes leaders hailing from Abbott Nutrition, Mead Johnson, Boston Children's Hospital, ESPHGAN (European Society for Pediatric Gastroenterology, Hepatology and Nutrition). Plum Organics, Tel Aviv University's Sackler Faculty of Medicine, and Gastroenterology & Nutrition Institute of RAMBAM Medical Center.
For more information, visit: elsenutrition.com or @elsenutrition on Facebook and Instagram.
<<<
GrowGeneration Corporation (GRWG) - Oppenheimer: These 2 “Strong Buy” Stocks Are Poised to Surge by Over 80%
July 17, 2020
https://finance.yahoo.com/news/oppenheimer-2-stocks-poised-surge-135427733.html
GrowGeneration Corporation (GRWG)
Taking its place as the largest hydroponic equipment supplier in the U.S., GrowGeneration owns and operates specialty retail hydroponic and organic garden centers. Given its strong long-term growth narrative and its $6.95 share price, it’s no wonder GRWG recently earned a thumbs up from Oppenheimer.
Covering the stock for the firm, 5-star analyst Brian Nagel likes what he’s seeing, to put it lightly. “GRWG represents a leading, yet still early stage, up-and-coming retail chain within the rapidly expanding and dynamic market for hydroponic and organic gardening supplies,” he noted.
Speaking to its footprint, the company operates 27 stores in ten states. That said, over the next few years, Nagel estimates that new store additions, including acquisitions and greenfield expansions, could approach more than 20 units per year, putting its total number of locations at over 90 stores by 2023.
To help it reach its targets, the company is putting advanced infrastructure in place. As part of these efforts, GRWG implemented a new ERP system, and in June, the stores were connected to its website, allowing for BOPUS and other functionality.
Expounding on this, Nagel stated, “Key to our initial positive outlook for GRWG is our view that the GRWG business model is now approaching a point of increased sustained underlying scalability... Our initial analysis suggests that, as GRWG accelerates further acquisition and organic expansion efforts, the company should increasingly capitalize upon scale-related synergies and over time deliver even better profit and cash generation.”
Additionally, after an all-primary, secondary equity offering, GRWG’s cash position lands at over $52 million, with only $314,000 in short- and long-term debt. Based on this, Nagel thinks that the company should be able to fund its near- and longer-term expansion objectives.
With the analyst projecting that through 2023, adjusted EBITDA will reach roughly $55 million on total company revenue of more than $400 million, Nagel doesn’t believe GRWG’s full value has been built into the share price.
To this end, Nagel rates GRWG a Buy along with a $15 price target. This target indicates shares could skyrocket 110% in the next year. (To watch Nagel’s track record, click here)
Turning now to the rest of the Street, other analysts are on the same page. Only Buy ratings, 5, to be exact, have been issued in the last three months, so the consensus rating is a Strong Buy. The $10.20 average price target puts the potential twelve-month gain at 42%. (See GrowGeneration stock analysis on TipRanks)
<<<
>>> Polar Power Achieves Key Milestone in Its Solar Hybrid Systems and DC Generators for Telecom, Residential and Commercial with EPA Certification of its Toyota 1KS Natural Gas / LPG Engine
GlobeNewswire
January 7, 2020
https://finance.yahoo.com/news/polar-power-achieves-key-milestone-140010506.html
GARDENA, Calif., Jan. 07, 2020 (GLOBE NEWSWIRE) -- Polar Power, Inc. (POLA), a global provider of prime, backup and solar hybrid DC power solutions announced it has received certification from the Environmental Protection Agency (EPA) for Toyota 1KS natural gas and LPG engines used in Polar’s DC power systems.
As part of Polar Power’s ongoing diversification strategy, the company has been working to introduce lower emission, fuel efficient prime power and solar hybrid power systems targeting telecom, residential and commercial markets in sub 40 kw microgrid applications. Polar’s engineering team has worked for over twelve months to integrate proprietary control technology with a long-life Toyota engine and Bosch engine controls designed to address the growing market for prime power, CHP and backup power needs worldwide. Polar is currently the only US company to achieve EPA certification for this Toyota 1KS engine that operates on natural gas and LPG (liquid petroleum gas refers to propane or combinations of propane and butane gases).
In the 1980’s this .952-liter Toyota engine was first developed by Daihatsu to run 24/7 for natural gas fueled heat pumps (GHP) used for air-conditioning and heating (HVAC). The GHP products were created in response to a Japanese government mandate that HVAC installations operated off the natural gas grid as opposed to the electric grid. This application in Japan has been very successful due to the high fuel efficiency, low maintenance and very long engine life. Polar, from 1998 to 2006, had purchased this Daihatsu engine through US distribution and incorporated it into its solar hybrid and prime power systems for residential and telecom markets. Toyota purchased Daihatsu in 1999 and eventually stopped its exports of these engines to the US. Polar dropped its sales efforts to residential markets but continued offering prime and backup generators using a Kubota engine for its telecom customers. Since acquiring Daihatsu in 1999 Toyota has made a significant improvement to the engine platform, including an electric carburetor and a further reduction in oil maintenance.
“We are excited to reach this key step in our growth strategy and diversification plan,” said Arthur Sams, Polar Power’s CEO. “We believe the growing demand for electric vehicle charging and HVAC will lead to more homes and businesses needing upgrades in electric power service, which is likely to exacerbate the problem of energy shortages and blackouts. Our CHP, natural gas vehicle chargers, and solar hybrid systems can solve the needs of many residences and small businesses without the potential high costs of utility service upgrades. Microgrids and distributed energy generation (DEG) is gaining mindshare and market share around the world driven by improving economics relative to utility power and better reliability. We believe our immediate opportunities are in applications demanding compelling economics, reliability and performance and based on these attributes Polar’s entrance into the sub 40 kW prime power market product should have little competition. There are very few manufactures providing a solution that has smaller footprint, lower noise levels, reduced maintenance, less fuel consumption and lower emissions. With tightening pollution requirements, we expect clean LPG and natural gas will over time replace diesel products in most stationary prime power generation applications. Having under 40 kW prime power generators that operate on natural gas and LPG gives us a competitive advantage over the many generators manufactures that do not offer LPG or natural gas generators in the smaller size ranges.”
“We see our Toyota based generator products offering significantly lower CAPEX and OPEX costs over a variety of other power systems including fuel cells. For example, Toyota recommends the maintenance interval at 8,600 hours (requiring a change of oil, spark plug and filters at a cost of $150). Our interviews with PEM fuel cell manufacturers that are competing to provide systems in the telecom markets, stated a need to replace the PEM membrane stack at between 4,500 to 6,000 hours at a cost of 60% of the system or around $9,000 for 15 kW configurations.
Furthermore, comparing our product against the most popular generator brands based on maintenance will help illustrate our advantages:
Oil and filter maintenance: Polar - 8,600 hours, Major Brand - 200 hours
Spark plugs: Polar - 8,600 hours, Major Brand – 400 hours
Engine service life: Polar - 40,000 to 90,000 hours, Major Brand – 2,000 to 3,000 hours
Generator service life: Polar - 100,000 + hours, Major Brand – 3,000 hours
Starting battery replacement: Polar - 15 years (we use a capacitor), Major Brand, every 2 to 4 years
“Incumbent generator technology has numerous shortfalls when it comes to backing up the grid for days or weeks at a time. For example, using traditional backup generators on a continuous operating basis, the user will have to change the oil every 9 days compared to Polar’s solution at once a year. At 3,000 hour engineered design life, home backup generators will last only 125 days verses 10 years for a Polar solution. Our backup solutions will be marketed to high-end applications where owners are looking for almost no maintenance, a long life and higher reliability.
“We will first target off-grid residential applications where we can provide a cost competitive Solar Hybrid, CHP and micro-cogeneration solution. For grid connected residences and business we will target geographies with unreliable grids that suffer from extended blackouts or markets with greater levels of electrical vehicle penetration and high utility rates during peak hours.”
Mr. Sams continued, “Although our focus is on the higher end of the market, the opportunity is significant. As an example, in California there are 4.88 million solar powered homes, 570,000 electric vehicles and 1.18 million residential homes with pools that can benefit from lower cost power generation via CHP during peak hours. In addition, there are significant off-grid power needs in agricultural and residential applications across the nation. We are currently developing our distribution and sales strategy and expect to begin pilot deployments throughout 2020. Initially we plan to work with LPG and natural gas fuel suppliers and distributors globally to leverage existing distribution networks for sales and service.”
Mr. Sams concluded, “We believe our DC power solutions are well suited and economically competitive for numerous markets outside of backup power for telecom and that our technology provides a superior solution over incumbent systems. Upon review of various new market opportunities for our products, we believe we have an economically competitive solution for applications in the low emission, high reliability residential and commercial microgrid markets. This should provide us with a compelling additional near-term growth opportunity beyond our established presence in the global telecommunication markets.”
About Polar Power, Inc.
Gardena, California-based Polar Power, Inc. (POLA), designs, manufactures and sells direct current, or DC, power systems, lithium battery powered hybrid solar systems for applications in the telecommunications market and, in other markets, including military, electric vehicle charging, cogeneration, distributed power and uninterruptable power supply. Within the telecommunications market, Polar’s systems provide reliable and low-cost energy for applications for off-grid and bad-grid applications with critical power needs that cannot be without power in the event of utility grid failure. For more information, please visit www.polarpower.com. or follow us on www.linkedin.com/company/polar-power-inc/
<<<
>>> GrowGeneration Announces $35,000,000 Follow-On Public Offering
PR Newswire
June 10, 2020
https://finance.yahoo.com/news/growgeneration-announces-35-000-000-120000335.html
DENVER, June 10, 2020 /PRNewswire/ - GrowGeneration Corp. (NASDAQ: GRWG), ("GrowGen" or the "Company"), the largest chain of stand-alone specialty hydroponic and organic garden centers, today announced that it has publicly filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission relating to a proposed follow-on public offering raising $35,000,000. In connection with the offering, GrowGen expects to grant the underwriters a 30-day option to purchase up to an additional 15% of the shares of common stock offered in the public offering.
Oppenheimer & Co. is acting as the sole book-running manager for the proposed offering. Ladenburg Thalmann & Co. Inc. and Lake Street Capital Markets are acting as co-managers for the offering.
The proposed offering is being made only by means of a prospectus. Copies of the preliminary prospectus, when available, may be obtained from: Oppenheimer & Co. Inc., Attn: Syndicate Prospectus Department, 85 Broad Street, 26th Floor, New York, New York 10004, by telephone at (212) 667-8055, or by email at EquityProspectus@opco.com. A registration statement relating to these securities has been filed with the U.S. Securities and Exchange Commission but has not yet become effective. These securities may not be sold, nor may offers to buy be accepted, prior to the time the registration statement becomes effective. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
About GrowGeneration Corp.:
GrowGen owns and operates specialty retail hydroponic and organic gardening stores. Currently, GrowGen has 27 stores, which include 5 locations in Colorado, 5 locations in California, 2 locations in Nevada, 1 location in Washington, 4 locations in Michigan, 1 location in Rhode Island, 4 locations in Oklahoma, 1 location in Oregon, 3 locations in Maine and 1 location in Florida. GrowGen also operates an online superstore for cultivators, located at www.growgen.pro and www.growgeneration.com. GrowGen carries and sells thousands of products, including organic nutrients and soils, advanced lighting technology and state of the art hydroponic equipment to be used indoors and outdoors by commercial and home growers. The Company's mission is to own and operate GrowGeneration branded stores in all the major states in the US and Canada. Management estimates that roughly 1,000 hydroponic stores are in operation in the US. By 2025, the global hydroponics system market is estimated to reach approximately $16 billion.
<<<
REED - >>> Flying Cauldron™ Launches on Amazon
Reeds, Inc.
GlobeNewswire
July 14, 2020
https://finance.yahoo.com/news/flying-cauldron-launches-amazon-125500891.html
Wands at the Ready! Butterscotch Cream Soda Brings Wizardry to Doorsteps Nationwide
NORWALK, Conn., July 14, 2020 (GLOBE NEWSWIRE) -- Flying Cauldron™, a non-alcoholic butterscotch cream soda from Reed’s® Inc. (NASDAQ: REED), proudly announces the magical brew’s launch on Amazon. It is now easier than ever to enjoy this out-of-this-world, butterscotch beer with a magical delivery straight to consumers' doorsteps.
Flying Cauldron™ leaves drinkers spellbound with an enchanting flavor experience that combines butterscotch with creamy vanilla. Perfectly served in an ice-cold mug, straight from the bottle or with a scoop of ice cream, the bewitching beverage is made with natural ingredients and no artificial flavors, sweeteners, preservatives, gluten, caffeine or GMOs.
“Consumers are looking for simple ways to spark happiness these days. From theme parties to marathon movie nights and anytime in between, Flying Cauldron™ ‘brews’ joy,” shared Lindsay Martin, Vice President of Marketing at Reed’s® Inc. “Fans of the brew have asked for Flying Cauldron™ doorstep delivery and, now with Amazon, it is easier than ever to taste the magic of our buttery, vanilla cream soda!”
For the magic-obsessed nationwide, Flying Cauldron™ will be giving away five cases of their butterscotch beer, along with sweet treats from Toasted Mallow, for one lucky winner. Until July 31st, wizards and witches can grab their wands, press their dress robes and enter the sweepstakes through Facebook and Instagram for a chance to win. More details on the sweepstakes are available here.
Flying Cauldron™ is available directly on Amazon for $24.99/12-Pack. The brand is offering 10% discount through July 31st with the code: 10FLYING.
For more information about Flying Cauldron™, please visit: https://flyingcauldron.com/. Follow Flying Cauldron™ on Twitter, Instagram, and Facebook.
About Reed's, Inc.
Established in 1989, Reed's® is America's # 1 name in Ginger and America’s best-selling Ginger Beer brand and innovator for decades. Under Reed's® Inc., Virgil's® is America's best-selling independent, full line of natural craft sodas, and Flying Cauldron™ is a unique line of non-alcoholic butterscotch cream soda. The Reed's® portfolio is sold in over 35,000 retail doors nationwide. Reed's® core product line of Original, Extra and Strongest Craft Ginger Beers, along with the Certified Ketogenic Zero Sugar Extra Ginger Beer are unique due to the proprietary process of using fresh ginger root combined with a Jamaican inspired recipe of natural spices and fruit juices.
<<<
>>> Else Nutrition Signs Key U.S. Retail Broker Agreements Ahead of Toddler Product Launch
CNW Group
July 13, 2020
https://finance.yahoo.com/news/else-nutrition-signs-key-u-110000465.html
Else Nutrition engages natural food brokers to bolster push into U.S. natural food retail chains.
VANCOUVER, BC , July 13, 2020 /CNW/ - ELSE NUTRITION HOLDINGS INC. (TSXV: BABY) (BABYF) (0YL.F) ("Else" or the "Company"), is pleased to announce that as part of its pathway to commercialization in the U.S. market, it has completed and signed broker agreements with two (2) reputable, natural food retail brokers, and is close to signing with a third broker. The food brokers' network spans Southern California , Arizona and Nevada , Northern California and the Northwest States, and the North East (including New York City ).
"These key broker agreements will significantly accelerate our push to get our product on the shelves of U.S. Natural Food chains. This marks major step towards bringing our clean, plant-based nutrition for toddlers to market, and making it accessible to parents and children at their local retail outlets. We have experienced significant in-bound positive feedback from the launch of our sample packets and we are excited to get the product into the hands of more consumers," said Ms. Hamutal Yitzhak , CEO and Co-Founder of Else.
Customers in the U.S. and Canada will soon be able to pre-order the full-sized Else Nutrition Plant-Based Complete Nutrition for Toddlers on the Else e-store at: www.elsenutrition.com.
About Else Nutrition Holdings Inc.
Else Nutrition GH Ltd. is an Israel -based food and nutrition company focused on developing innovative, clean and plant-based food and nutrition products for infants, toddlers, children, and adults. Its revolutionary, plant-based, non-soy, formula is a clean-ingredient alternative to dairy-based formula. Else Nutrition (formerly INDI) won the "2017 Best Health and Diet Solutions" award at the Global Food Innovation Summit in Milan . The holding company, Else Nutrition Holdings Inc, is a publicly-traded company, listed as TSX Venture Exchange under the trading symbol BABY and is quoted on the US OTC Markets QB board under the trading symbol BABYF and on the Frankfurt Exchange under the symbol 0YL. Else's Executive and Advisory Board includes leaders hailing from Abbott Nutrition, Mead Johnson, Boston Children's Hospital, ESPGHAN (European Society for Pediatric Gastroenterology, Hepatology and Nutrition). Plum Organics, Tel Aviv University's Sackler Faculty of Medicine, and Gastroenterology & Nutrition Institute of RAMBAM Medical Center.
<<<
>>> First Patient Infused in Joint Humanigen/Kite, A Gilead Company Clinical Study
Business Wire
June 30, 2020
https://finance.yahoo.com/news/first-patient-infused-joint-humanigen-110000705.html
First Patient Infused in Joint Humanigen/Kite, A Gilead Company Clinical Study
ZUMA-19 study being conducted as part of a clinical collaboration in the U.S.
Study evaluating the potential effects of lenzilumab (anti-human-GM-CSF monoclonal antibody) prior to Yescarta® (axicabtagene ciloleucel) in adults with relapsed or refractory large B-cell lymphoma
Humanigen, Inc., (HGEN) ("Humanigen"), a clinical stage biopharmaceutical company focused on preventing and treating cytokine release syndrome (CRS) with lenzilumab, the company’s proprietary Humaneered® anti-human granulocyte macrophage-colony stimulating factor (GM-CSF) monoclonal antibody, announced that the first patient has been infused in the ZUMA-19 study, which is being conducted in collaboration with Kite, A Gilead Company. Details of the ZUMA-19 study can be found at www.clinicaltrials.gov/ct2/show/NCT04314843.
"We are excited to see this clinical collaboration move forward as we seek to understand the potential benefit of lenzilumab being administered with CAR T therapy in patients with relapsed or refractory large B-cell lymphoma," said Cameron Durrant, MD, chief executive officer of Humanigen.
About Humanigen, Inc.
Humanigen, Inc. is developing its portfolio of clinical and pre-clinical therapies for the treatment of cancers and infectious diseases via its novel, cutting-edge GM-CSF neutralization and gene-knockout platforms. We believe that our GM-CSF neutralization and gene-editing platform technologies have the potential to reduce the inflammatory cascade associated with coronavirus infection. The company’s immediate focus is to prevent or minimize the cytokine release syndrome that precedes severe lung dysfunction and ARDS in serious cases of SARS-CoV-2 infection. The company is also focused on creating next-generation combinatory gene-edited CAR-T therapies using strategies to improve efficacy while employing GM-CSF gene knockout technologies to control toxicity. In addition, the company is developing its own portfolio of proprietary first-in-class EphA3-CAR-T for various solid cancers and EMR1-CAR-T for various eosinophilic disorders. The company is also exploring the effectiveness of its GM-CSF neutralization technologies (either through the use of lenzilumab as a neutralizing antibody or through GM-CSF gene knockout) in combination with other CAR-T, bispecific or natural killer (NK) T cell engaging immunotherapy treatments to break the efficacy/toxicity linkage, including to prevent and/or treat graft-versus-host disease (GvHD) in patients undergoing allogeneic hematopoietic stem cell transplantation (HSCT). Additionally, Humanigen and Kite, a Gilead Company, are evaluating lenzilumab in combination with Yescarta® (axicabtagene ciloleucel) in patients with relapsed or refractory large B-cell lymphoma in a clinical collaboration. For more information, visit www.humanigen.com
<<<
>>> GrowGeneration Set to Join Russell 3000® Index
Yahoo Finance
June 11, 2020
https://finance.yahoo.com/news/growgeneration-set-join-russell-3000-120000547.html
GrowGeneration Corp. (NASDAQ:GRWG), ("GrowGen" or the "Company"), the largest chain of stand-alone specialty hydroponic and organic garden centers, currently with 27 locations, announced today it is set to join the broad-market Russell 3000® Index. GrowGeneration's inclusion in the Russell 3000® Index will take place at the conclusion of the 2020 Russell indexes annual reconstitution, effective after the US market opens on June 29, according to a preliminary list of additions posted June 5.
<<<
>>> EnWave Signs Commercial License and Equipment Purchase Agreement with Pick-One S.A. de CV Following Successful Evaluation
MarketWatch
July 8, 2020
https://www.marketwatch.com/press-release/enwave-signs-commercial-license-and-equipment-purchase-agreement-with-pick-one-sa-de-cv-following-successful-evaluation-2020-07-08?siteid=bigcharts&dist=bigcharts&tesla=y
The MarketWatch News Department was not involved in the creation of this content.
VANCOUVER, British Columbia, Jul 08, 2020 (GLOBE NEWSWIRE via COMTEX) -- EnWave Corporation (TSX-V:ENW | FSE:E4U) ("EnWave", or the "Company") announced today that it has signed a non-exclusive, royalty-bearing commercial license agreement (the "License") with Pick-One S.A. de CV ("Pick-One") to produce dried cheese and fruit snacks using Radiant Energy Vacuum ("REV(TM)") technology for the retail grocery market in Mexico. Under the terms of the License, Pick-One purchased the 10kW commercial REV(TM) machine to initiate commercial production in Mexico.
This License is the first signed by EnWave with a Mexican partner, opening up a major North American market with a rich agricultural industry. Pick-One has been using a 10kW REV(TM) machine at their Chihuahua manufacturing facility under a Technology Evaluation and License Option Agreement ("TELOA") since late 2019 for product development purposes. As a result of Pick-One's successful development of shelf-stable snack prototypes, they decided to purchase the machine outright and commence commercial-scale production.
Pursuant to the terms of the License, Pick-One will make undisclosed quarterly royalty payments to the Company calculated as a percentage of the revenue generated from their commercial success. EnWave will continue to collaborate with Pick-One to optimize processing efficiencies and help bring improved snack products to market. To-date, EnWave has signed 38 royalty-bearing commercial licenses with food, cannabis and pharmaceutical companies globally.
The expansion of EnWave's global REV(TM) technology footprint into Mexico further proves the significant value proposition for food processors seeking to launch new and innovative premium snack food applications. EnWave holds a robust intellectual property portfolio spanning numerous international markets and has licensed REV(TM) technology to food companies in seventeen countries worldwide.
About Pick-One
Pick-One is a 100% Mexican owned company born from the idea of ??????bringing healthy and delicious products to market. Through the company's commitment to adopting innovative processes and unique flavor profiles, Pick-One has chosen to adopt REV(TM) technology at commercial scale to expand its product portfolio.
For more information, please visit www.pick-one.mx.
About EnWave
EnWave Corporation, a Canadian advanced technology company, has developed Radiant Energy Vacuum ("REV(TM)") - an innovative, proprietary method for the precise dehydration of organic materials. EnWave has further developed patented methods for uniformly drying and decontaminating cannabis through the use of REV(TM) technology, shortening the time from harvest to marketable cannabis products.
REV(TM) technology's commercial viability has been demonstrated and is growing rapidly across several market verticals in the food, and pharmaceutical sectors, including legal cannabis. EnWave's strategy is to sign royalty-bearing commercial licenses with innovative, disruptive companies in multiple verticals for the use of REV(TM) technology. The company has signed over thirty royalty-bearing licenses to date. In addition to these licenses, EnWave established a Limited Liability Corporation, NutraDried Food Company, LLC, to manufacture, market and sell all-natural dairy snack products in the United States, including the Moon Cheese brand.
EnWave has introduced REV(TM) as a disruptive dehydration platform in the food and cannabis sectors: faster and cheaper than freeze drying, with better end product quality than air drying or spray drying. EnWave currently offers two distinct commercial REV(TM) platforms:
-- nutraREV which is a drum-based system that dehydrates organic materials quickly and at low-cost, while maintaining high levels of nutrition, taste, texture and colour; and,
-- quantaREV which is a tray-based system used for continuous, high-volume low-temperature drying.
EnWave is also active in the pharmaceutical industry through a joint development agreement with GEA Lyophil, a leader in GMP drying machinery.
More information about EnWave is available at www.enwave.net.
<<<
>>> John B. Sanfilippo & Son, Inc. Board Declares Special Cash Dividend of $1.85 per share of Common Stock and Class A Common Stock and Regular Annual Cash Dividend of $0.65 per share of Common Stock and Class A Common Stock
Business Wire
July 9, 2020
https://finance.yahoo.com/news/john-b-sanfilippo-son-inc-200500312.html
John B. Sanfilippo & Son, Inc. Board Declares Special Cash Dividend of $1.85 per share of Common Stock and Class A Common Stock and Regular Annual Cash Dividend of $0.65 per share of Common Stock and Class A Common Stock
John B. Sanfilippo & Son, Inc. (NASDAQ: JBSS) (the "Company") today announced that its Board of Directors (the "Board") declared a special cash dividend (the "Special Dividend") of $1.85 per share on all issued and outstanding shares of Common Stock of the Company and $1.85 per share on all issued and outstanding shares of Class A Common Stock of the Company. In addition to the Special Dividend, the Board declared a regular annual cash dividend (the "Annual Dividend") of $0.65 per share on all issued and outstanding shares of Common Stock of the Company and $0.65 per share on all issued and outstanding shares of Class A Common Stock of the Company. The aggregate payment for both the Special Dividend and Annual Dividend will be approximately $29.0 million.
The Special Dividend and the Annual Dividend will be paid on August 21, 2020 to stockholders of record as of the close of business on August 7, 2020.
"We are pleased to announce the $1.85 per share Special Dividend and the $0.65 per share Annual Dividend," stated Jeffrey T. Sanfilippo, Chairman and Chief Executive Officer. "Our financial performance in the first three quarters of fiscal 2020 has provided us the opportunity to declare the Special Dividend and increase our Annual Dividend by $0.05 per share over last year’s Annual Dividend. These dividends, like our previous dividends, further reinforce our goal of creating long-term stockholder value through the responsible use of cash. Furthermore, these dividends would not be possible without the hard work and dedication of all our employees," Mr. Sanfilippo concluded.
ABOUT THE COMPANY
John B. Sanfilippo & Son, Inc. is a processor, packager, marketer and distributor of nut and dried fruit-based products that are sold under a variety of private brands and under the Company’s Fisher®, Orchard Valley Harvest®, Squirrel Brand®, Southern Style Nuts® and Sunshine Country® brand names.
<<<
>>> Arcimoto, Inc. (FUV) - Strong Insider Buying
Yahoo Finance
July 6, 2020
https://finance.yahoo.com/news/3-stocks-flashing-signs-strong-144618221.html
The next company on our list, Arcimoto, is an Oregon-based ‘green economy’ player. Arcimoto has developed, and is marketing, a series of low-weight, high-efficiency electric vehicles. The company’s name for the line, Fun Electric Vehicle, is also the source of its stock ticker, FUV.
Over the past year, Arcimoto has expanded its EV designs to include delivery vehicles and rental fleet options. The company was forced to suspend manufacturing operations during the coronavirus crisis, but has since reopened its assembly facilities.
In a move to raise capital and expedite recovery from the pandemic’s impact, Arcimoto put 1.7 million shares of common stock on the market at the end of June. The move grossed $8.5 million, the proceeds of which will be used for general working capital, including acceleration of manufacture and delivery of pre-ordered vehicles.
The offering was an opportunity for insiders, as well as the public, and three company officers made significant purchases in recent days. Mark Frohnmayer, company President, bought 78,531 shares for an estimated $334,000, and two board members, Jesse Grant Eisler and Joshua Scherer, also made six-figure purchases. These were informative buys, the first in a year, and have moved the company’s insider sentiment far more positive than its sector average.
Amit Dayal, 4-star analyst with H.C. Wainwright, is bullish on Arcimoto, rating the stock a Buy and writing, “We once again reiterate the 'multiple shots on goal' aspect of the company's market positioning, where one vehicle platform has the flexibility to serve multiple applications and markets. Accordingly, pushouts in vacation oriented sales should, in our opinion, be compensated with pickup in delivery applications... The company's cash burn was lowered during the lockdown but should be expected to ramp with production picking up.”
Dayal’s $7 price target suggests that FUV has room for 3% growth over the next 12 months.
Recent share appreciation – the stock rose an eye-opening 378% in Q2 – has pushed FUV above the average price target, too fast for most analysts to adjust their outlooks. Shares are currently selling for $6.82, so the $5.38 average price target puts the downside potential at 21%. The Strong Buy analyst consensus rating is unanimous, based on 4 recent positive reviews.
<<<
>>> Village Farms International, Inc., together with its subsidiaries, produces, markets, and distributes greenhouse-grown tomatoes, bell peppers, and cucumbers in North America. It operates through three segments: Produce Business, Energy Business, and Cannabis and Hemp Business. The company also owns and operates a 7.0 megawatt power plant that generates and sells electricity to British Columbia Hydro and Power Authority; and produces and supplies cannabis products. It markets and distributes its products under the Village Farms brand name to retail supermarkets and fresh food distribution companies, as well as products produced under exclusive arrangements with other greenhouse producers. The company was formerly known as Village Farms Canada Inc. and changed its name to Village Farms International, Inc. in December 2009. Village Farms International, Inc. was founded in 1989 and is headquartered in Delta, Canada. <<<
>>> Else Nutrition Announces the U.S. Launch of Trial Samples of its Plant-based Nutrition Product for Toddlers
CNW Group
June 22, 2020
https://finance.yahoo.com/news/else-nutrition-announces-u-launch-110000651.html
Plant-based Complete Nutrition for Toddlers Trial Pouches to be widely available on ElseNutrition.com e-store
VANCOUVER, BC , June 22, 2020 /CNW/ - ELSE NUTRITION HOLDINGS INC.
(BABY.V) (BABYF) (0YL.F) ("Else" or the "Company"), is pleased to announce the U.S. launch of trial-sized pouches of Else Plant -based Complete Nutrition for Toddlers.
Following successful production, the trial samples of Else's proprietary product will now be widely available for order via the elsenutrition.com e-store.
"We are thrilled to hit this key milestone and to be sharing our product with the world. It is indeed a major inflection point as we continue down the path toward commercialization of our first product. We are excited to get the samples in the hands of eager parents looking for clean label, plant-based nutrition alternatives for their children," said Ms. Hamutal Yitzhak , CEO & Co-Founder.
Else Plant-Based Complete Nutrition for Toddlers trial pouches (1.27 oz) will be available at no charge, with customers covering only the shipping costs. The sampling campaign will be promoted via Else social media channels and will precede the launch of the full-size version of the product, which will be available for pre-orders on our e-store this July.
Samples can be ordered at: www.elsenutrition.com.
About Else Nutrition Holdings Inc.
Else Nutrition GH Ltd. is an Israel-based food and nutrition company focused on developing innovative, clean and plant-based food and nutrition products for infants, toddlers, children, and adults. Its revolutionary, plant-based, non-soy, formula is a clean-ingredient alternative to dairy-based formula. Else Nutrition (formerly INDI) won the "2017 Best Health and Diet Solutions" award at the Global Food Innovation Summit in Milan. The holding company, Else Nutrition Holdings Inc, is a publicly-traded company, listed as TSX Venture Exchange under the trading symbol BABY and is quoted on the US OTC Markets QB board under the trading symbol BABYF and on the Frankfurt Exchange under the symbol 0YL. Else's Executive and Advisory Board includes leaders hailing from Abbott Nutrition, Mead Johnson, Boston Children's Hospital, ESPGHAN (European Society for Pediatric Gastroenterology, Hepatology and Nutrition), University Hospital Brussels, Tel Aviv University's Sackler Faculty of Medicine, and Gastroenterology & Nutrition Institute of RAMBAM Medical Center, Plum Organics.
<<<
>>> McEwen Mining Closes the Refinancing of Its $50 Million Debt
GlobeNewswire
June 25, 2020
https://finance.yahoo.com/news/mcewen-mining-closes-refinancing-50-210141677.html
TORONTO, June 25, 2020 (GLOBE NEWSWIRE) -- McEwen Mining Inc. (MUX.TO) (MUX.TO) (“McEwen” or the “Company”) is pleased to announce that it has successfully refinanced its $50 million senior secured term loan facility (the “Term Loan”). As part of the refinancing, Sprott Private Resource Lending II (Collector), LP has replaced Royal Capital Management Corp. as a lender and the administrative agent for the Term Loan; and Evanachan Limited, a corporation wholly-owned by Rob McEwen, remains a lender (collectively the “Lenders”). The principal amount of the loan remains $50 million.
As part of the amendments, the maturity date of the Term Loan has been extended by two years to August 31, 2023. In consideration for the extension of the Term Loan and other amendments, the Lenders were paid one-time bonus interest of 3.75% of the principal amount of the Term Loan in the form of restricted shares of the Company. A total of 2,091,700 common shares were issued to the Lenders pro rata in connection with the refinancing.
The principal amount of the Term Loan will continue to bear interest at 9.75%, payable monthly. Principal payments of $2 million per month are now scheduled to begin two years later on August 31, 2022, and the final principal payment is due on August 31, 2023. The Term Loan can be retired in full or in part any time prior to December 31, 2021 upon payment of the principal and accrued interest plus a fee linked to the remaining life of the Term Loan, and after December 31, 2021 upon the payment of the remaining principal and accrued interest plus a fee equal to 3% of the remaining principal.
<<<
>>> Else Nutrition (TSXV:BABY) is Another of Rich’s Top Picks for 2020
Rich TV Live
12-19-20
https://richtvlive.com/else-nutrition-rich-pick-2020/
Else Nutrition Holdings Inc. (TSXV:BABY) (OTCPK:BABYF) is a food and nutrition company that focuses on researching, developing, manufacturing, marketing, selling, and/or licensing plant-based food and nutrition products. These products are targeted for the infant, toddler, children, and adult markets.
Rich first brought BABY to the attention of his community in October. Just days after that video, the stock rose an astounding 61%! Now, as 2020 quickly approaches, Rich returns with another bullish BABY profile.
“You need to put BABY on your watch list, you need to put it on your radar,” he says. “I think Else Nutrition is going to be a beast in 2020.”
The Plant-Based Food and Formula Boom
You most likely already know about the great success of Beyond Meat (NASDAQ:BYND). The alternate meat stock had the best IPO of 2019, primarily because it has the first-mover advantage delivering plant-based foods to hungry consumers.
But plant-based foods aren’t just replacing meat products like burgers, pork, and chicken. They’re also creating healthier and safer food for babies, children, and adults.
The worldwide industry for infant formula is expected to reach $90 billion in value by 2025. As more parents than ever before are looking for healthier options for their children, Else Nutrition’s breakthrough, 100% plant-based, non-soy infant formula could not come at a better time.
Else Nutrition’s First Mover Advantage
The formula is the first of its kind on the market. Made from almonds and buckwheat, Else Nutrition’s formula is free of GMOs, pesticides, hormones, antibiotics, gluten, and phytoestrogens. This makes it a healthier and more natural option for toddlers (12–36 months) than dairy-based baby formulas.
Right now, the vast majority of infant formulas are milk-based. This unfortunately ignores the fact that cow’s milk is the number one allergen for children aged five or younger. Milk allergies currently affect half of all food-allergic children in America who are less than one year old.
On top of that, nearly all alternatives to milk-based formulas are soy-based. Yet approximately 40% percent of children allergic to cow’s milk are also allergic to soy milk.
This means there are millions of children who can’t drink cow’s milk nor any of the alternatives, save for Else Nutrition’s 100% plant-based formula. This kind of exclusive market reach is unprecedented, especially in a market as important as children’s health and nutrition.
In addition to its strong product offering, Else Nutrition has very strong IP protection. This is an important part of its plan to capitalize on being the first mover in the plant-based infant formula space.
BABY’s formula has been granted patents in 20 countries, including the United States, Australia, Japan, Ukraine, Israel, Russia, South Africa, and New Zealand. The company also has a further 50+ patents pending.
Finally, Else Nutrition is already earning revenue in Israel from the sale of its vegan baby snacks and various accessories. These products generated $900,000 for the company last year and will be launched in the US next year.
BABY’s Performance
This morning, BABY stock jumped 16%, from $0.37 to $0.43. As the company gets ever closer to launching its products on the American market, investors and analysts are sure to take note of this exciting stock.
“We’ve got, like, three months before this BABY explodes,” says Rich. “They are pre-revenue, but they’re not far from it. In my opinion they are going to at least $1.00 next year, once they start posting revenue.”
What do you think? Is BABY bound to take off? Let us know what you think.
<<<
>>> Else Nutrition Aims to Disrupt Baby and Child Nutrition Forever, with Plant-Based, Non-Dairy/Non-Soy Nutrition
Feb 25, 2020
https://www.marketwatch.com/press-release/else-nutrition-aims-to-disrupt-baby-and-child-nutrition-forever-with-plant-based-non-dairynon-soy-nutrition-2020-02-25?siteid=bigcharts&dist=bigcharts
Baby Food Industry Veterans Launch Revolutionary, Clean Ingredient and Process, Plant-based Toddler Nutrition
VANCOUVER, British Columbia, Feb. 25, 2020 /PRNewswire/ -- Else Nutrition, a game-changing developer and marketer of clean-ingredient, plant-based nutrition products, is launching its first commercial product this spring in the U.S. – following nearly seven years of research and development. It's a next-generation, 100 percent plant-based, organic toddler nutrition made with a proprietary formulation of almonds, buckwheat, and tapioca. The globally-patented, toddler nutritional drink (toddler formula) tastes great, contains zero dairy or soy, and is free of gluten, hormones, antibiotics, palm oil, and corn syrups.
The startup, founded by infant nutrition veterans, fills a market gap, with plant-based toddler nutrition (for ages 12-36 months) made with clean, whole ingredients from whole foods. The simple-to-use powder is the first in a planned line of whole-meal nutrition products from Else for children of ages ranging from infant to teens.
"As a mother, I know how passionate parents are to ensure that their children get all the nutrients they need for fundamental growth and development. We are providing a solution for millions of parents worldwide who are looking to change the way they feed their kids by offering a clean, safe, and nutritious, plant-based nutrition option. We've heard from thousands of parents worldwide that there's a need for something else – a real viable alternative," said Hamutal Yitzhak, Co-Founder and CEO of Else Nutrition Holdings Inc. Else is based in Tel Aviv, Israel, and started trading on the Toronto stock exchange last June.
For nearly 120 years, the infant and toddler formula markets have been based on dairy and soy protein sources. Else prides itself on offering a real alternative. Else provides complete nutrition made from simple ingredients and a clean process. Else is plant-based, sustainable, organic, and vegan.
The plant-based toddler nutrition drink offers a full essential amino acid profile, and is a clean non-GMO source of protein, fully meeting the strictest regulatory requirements. Else's 'beyond organic' disruptive manufacturing processes include the transformation of whole plants, without using highly-processed extracts or derivatives, chemicals or high-fructose corn syrup.
Else's toddler nutrition will be sold initially in powder form, ready to drink in just seconds. It will be available online at elsenutrition.com for pre-ordering, with official sales starting later in Q2 at the same e-Store. Sales will also roll-out via Amazon, and at select specialty retailers by the summer of 2020. The suggested retail price is $35 for a 23.2 oz. powder canister.
Else's leaders and founders have held executive positions with the likes of Abbott Laboratories, and Materna (a leading baby formula producer, acquired by Nestlé). The company was born out of the personal quest of a caring grandfather seeking to find a solution for his granddaughter who suffered from severe baby formula allergies. The company's vision is to transform feeding for babies and families worldwide. Else aims to launch its plant-based infant formula in the coming years.
About Else Nutrition Holdings Inc.
Else Nutrition GH ltd. is an Israel-based food and nutrition company focused on developing innovative, clean and plant-based food and nutrition products for infants, toddlers, children, and adults. Its revolutionary, 100% plant-based, non-soy, formula is a clean-ingredient alternative to dairy-based formula. Else Nutrition won the "2017 Best Health and Diet Solutions' award at the Global Food Innovation Summit in Milan. The holding company, ELSE Nutrition Holdings Inc, is a publicly-traded company, listed as TSX-V: BABY, as part of the TSX Venture Exchange and as OTCQB: BABYF as part of the NY OTC QB Exchange. Else's Executive and Advisory Board includes leaders hailing from Abbott Nutrition, Mead Johnson, Boston Children's Hospital, ESPHGAN (European Society for Pediatric Gastroenterology, Hepatology and Nutrition). Plum Organics, Tel Aviv University's Sackler Faculty of Medicine, and Gastroenterology & Nutrition Institute of RAMBAM Medical Center.
<<<
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |